Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys_老虎社区_美港股上老虎

Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys

Prosper Junior Bakiny2021-03-16

The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

ShiJun
·2021-03-17
comment :)
回复
点赞
举报
MJ2317
·2021-03-17
Good
回复
点赞
举报
henryee18
·2021-03-17
Dang, the stocks raise too quick.
回复
点赞
举报
pinghu
·2021-03-17
[财迷]
回复
点赞
举报
Kayabunz
·2021-03-17
Vaccines vaccines
回复
1
举报
Yyangyang
·2021-03-17
Read.
回复
1
举报
TeeNyKoH
·2021-03-17
n
回复
3
举报
小刀锯大树还不算事
·2021-03-17
Popular is the keyword.
回复
点赞
举报
Sheryl85
·2021-03-17
ok noted
回复
3
举报
capsulefong
·2021-03-17
Nice
回复
2
举报
Kuxn
·2021-03-17
Good write up
回复
5
举报
收起
- ZelHo:
  Yes
  2021-03-17
  回复
  举报
- Nicolas_Lim_:
  yes
  2021-03-19
  回复
  举报
- Kuxn:
  HAAHAHA CB
  2021-03-21
  回复
  举报
kawa86
·2021-03-17
buy buy buy
回复
3
举报
收起
- kawa86:
  like & comment
  2021-03-17
  回复
  举报
CL777
·2021-03-17
More gambling?
回复
3
举报
Haohao2324
·2021-03-17
Hi
回复
1
举报
Tarnek
·2021-03-17
buy buy buy
回复
1
举报
收起
- Haohao2324:
  Like
  2021-03-17
  回复
  举报
kcwang4982
·2021-03-17
Good
回复
3
举报
Ultrarich
·2021-03-17
Robbinthehood? Not sure
回复
点赞
举报
Rorym
·2021-03-17
Wow really good read
回复
4
举报
Erat
·2021-03-17
Hmm
回复
5
举报
JoshyQ
·2021-03-17
Cool cool cool
回复
点赞
举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2119619927?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-03-16 23:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2119619927","market":"us","top_or_hot":-1,"title":"Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys","media":"Prosper Junior Bakiny","content":"<div>\n<p>The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/\">网页链接</a>\n\n</div>\n","source":"fool_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nForget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-16 23:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/><strong>Prosper Junior Bakiny</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BPOPN","symbol_name":"Popular","start_time":0,"source_url":"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/","article_id":"2119619927","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2119619927","pubTimestamp":1615907700,"sourceInfo":{"source_id":"fool_stock","name":"Motley Fool"},"weMediaInfo":null,"summary":"No need to invest in faltering businesses -- these two winning companies are better bets.","collect":0,"end_time":0,"defaultTopTitle":"fool.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BPOPN":"Popular","BPOPM":"Popular"},"translate_title":"忘了AMC和游戏驿站吧：这两只受欢迎的罗宾汉股票是更好的购买对象","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BPOPM":0.9,"BPOPN":0.9},"content_text":"The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the list of the 100 most popular stocks on the platform. However, some of the stocks on that list are head-scratchers. For instance, GameStop (NYSE:GME) and AMC Entertainment (NYSE:AMC) are among the top 20 most commonly held stocks on the app as of this writing.Both of these businesses are struggling, in part due to their reliance on brick-and-mortar operations, which were severely impacted by the pandemic. Further, both AMC and Gamestop were at the center of the now (in)famous short-squeeze fiasco orchestrated by traders from Reddit's r/WallStreetBets. Investors would be better off staying away from these two unpredictable companies and instead purchasing shares of Robinhood stocks with solid futures ahead of them. Two such companies worth considering are Pfizer (NYSE:PFE) and Netflix (NASDAQ:NFLX).^SPX data by YCharts1. PfizerYou've probably heard a lot about Pfizer in the past few months. The company and its partner, BioNTech, developed BNT162b2, and received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) in December, becoming the first authorized COVID-19 vaccine in the U.S. BNT162b2 has also been approved in the European Union.While Pfizer and BioNTech have to share the vaccine supply gameboard with several other companies, including Johnson & Johnson, AstraZeneca, and Moderna, the market (i.e., the entire world) is large enough for there to be multiple winners. In other words, BNT162b2 will contribute meaningfully to Pfizer's top line, especially since there is evidence of it being effective against some of the newer variants of the virus.But the company's lineup is much bigger than just this one vaccine. Some of Pfizer's top-performing products include anticoagulant Eliquis and cancer treatments Ibrance and Xtandi. Sales of Eliquis for fiscal year 2020 (ended Dec. 31) were $4.9 billion, a 17% year-over-year increase. Ibrance's revenue jumped by 9% year over year to $5.4 billion, while Xtandi's sales came in at roughly $1 billion, representing 22% growth from fiscal year 2019.Pfizer also boasts 95 programs in its pipeline, including 24 ongoing phase 3 studies. Pfizer is well-positioned to keep adding new revenue sources to its lineup every year. Lastly, it is worth noting that Pfizer spun-off its off-patent medicine unit Upjohn to the company formerly known as Mylan. The combined entity of Mylan and Upjohn is called Viatris, and it started trading on the market on Nov. 17.Pfizer decided to make this move because Upjohn's declining sales were hurting its bottom line. The company can now focus on its more profitable biopharma business. This focus should help Pfizer improve its financial results, which will help its stock recover from its underperformance relative to the market in the past year.With a more focused business, a short-term catalyst in the form of its coronavirus vaccine, other medicines with growing sales, and a rich pipeline to keep revenue sources coming, this pharma stock looks like a much better long-term bet than AMC or GameStop.Image source: Getty Images2. NetflixNetflix is already one of the leading streaming video platforms in the world, but the company isn't done growing. What are the opportunities ahead for the tech giant? First, the company is looking to add even more users to its platform. As of its fourth quarter ending Dec. 31, the company had 8.51 million net new subscribers. It ended the period with a total of 203.7 million paid subscriptions, representing a year-over-year increase of 21.9%. Netflix thinks it will add 6 million new subscribers in the first quarter of 2021.And the streaming services industry as a whole has a long runway for growth. According to Grand View Research, this market was worth 50.1 billion in 2020, and it is projected to expand at a compound annual growth rate (CAGR) of 21% between 2021 and 2028.As one of the most recognizable names in this segment, Netflix is well-positioned to profit, especially since competing streaming platforms are more than capable of coexisting. One of the most powerful weapons in these platforms' arsenals is original content, and Netflix has been pouring money into original series and movies in the hopes of building a library people will want to keep coming back to.Image source: Getty Images.These investments have played an important role in the company's success in recent years. Since the content on Netflix is different from that of some of its peers, many customers are more than happy to pay for subscriptions to several companies in this space. The long-term plan for Netflix is simple: Replace regular TV.The company offers several advantages over cable: no ads, no long-term contracts, and on-demand movies and series streaming on any device. And while some cable providers have started to adapt to the new paradigm, Netflix is well on its way to continue its long winning streak in the streaming industry. Those factors make the company's stock worth a buy.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":324097466,"gmtCreate":1615942363655,"gmtModify":1703495279578,"author":{"id":"3574944998215364","authorId":"3574944998215364","name":"ShiJun","avatar":"https://static.tigerbbs.com/545e0913498b32c1a00eeba1047a0c92","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"comment :)","listText":"comment :)","text":"comment :)","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/324097466","repostId":2119619927,"repostType":4,"repost":{"id":"2119619927","pubTimestamp":1615907700,"share":"https://www.laohu8.com/m/news/2119619927?lang=&edition=full","pubTime":"2021-03-16 23:15","market":"us","language":"en","title":"Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys","url":"https://stock-news.laohu8.com/highlight/detail?id=2119619927","media":"Prosper Junior Bakiny","summary":"No need to invest in faltering businesses -- these two winning companies are better bets.","content":"<p>The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the list of the 100 most popular stocks on the platform. However, some of the stocks on that list are head-scratchers. For instance, <b>GameStop</b> (NYSE:GME) and <b>AMC Entertainment</b> (NYSE:AMC) are among the top 20 most commonly held stocks on the app as of this writing.</p><p>Both of these businesses are struggling, in part due to their reliance on brick-and-mortar operations, which were severely impacted by the pandemic. Further, both AMC and Gamestop were at the center of the now (in)famous short-squeeze fiasco orchestrated by traders from Reddit's r/WallStreetBets. Investors would be better off staying away from these two unpredictable companies and instead purchasing shares of Robinhood stocks with solid futures ahead of them. Two such companies worth considering are <b>Pfizer</b> (NYSE:PFE) and <b>Netflix</b> (NASDAQ:NFLX).</p><p><img src=\"https://media.ycharts.com/charts/693c6b3570e5dc157db6f1cb5d80481e.png\" tg-width=\"720\" tg-height=\"387\" referrerpolicy=\"no-referrer\"></p><p>^SPX data by YCharts</p><p><b>1. Pfizer</b></p><p>You've probably heard a lot about Pfizer in the past few months. The company and its partner, <b>BioNTech</b>, developed BNT162b2, and received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) in December, becoming the first authorized COVID-19 vaccine in the U.S. BNT162b2 has also been approved in the European Union.</p><p>While Pfizer and BioNTech have to share the vaccine supply gameboard with several other companies, including <b>Johnson &amp; Johnson</b>, <b>AstraZeneca</b>, and <b>Moderna</b>, the market (i.e., the entire world) is large enough for there to be multiple winners. In other words, BNT162b2 will contribute meaningfully to Pfizer's top line, especially since there is evidence of it being effective against some of the newer variants of the virus.</p><p>But the company's lineup is much bigger than just this <a href=\"https://laohu8.com/S/AONE\">one</a> vaccine. Some of Pfizer's top-performing products include anticoagulant Eliquis and cancer treatments Ibrance and Xtandi. Sales of Eliquis for fiscal year 2020 (ended Dec. 31) were $4.9 billion, a 17% year-over-year increase. Ibrance's revenue jumped by 9% year over year to $5.4 billion, while Xtandi's sales came in at roughly $1 billion, representing 22% growth from fiscal year 2019.</p><p>Pfizer also boasts 95 programs in its pipeline, including 24 ongoing phase 3 studies. Pfizer is well-positioned to keep adding new revenue sources to its lineup every year. Lastly, it is worth noting that Pfizer spun-off its off-patent medicine unit Upjohn to the company formerly known as Mylan. The combined entity of Mylan and Upjohn is called <b>Viatris</b>, and it started trading on the market on Nov. 17.</p><p>Pfizer decided to make this move because Upjohn's declining sales were hurting its bottom line. The company can now focus on its more profitable biopharma business. This focus should help Pfizer improve its financial results, which will help its stock recover from its underperformance relative to the market in the past year.</p><p>With a more focused business, a short-term catalyst in the form of its coronavirus vaccine, other medicines with growing sales, and a rich pipeline to keep revenue sources coming, this pharma stock looks like a much better long-term bet than AMC or GameStop.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F617555%2Fgettyimages-1291715271.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images</p><p><b>2. Netflix</b></p><p>Netflix is already <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leading streaming video platforms in the world, but the company isn't done growing. What are the opportunities ahead for the tech giant? First, the company is looking to add even more users to its platform. As of its fourth quarter ending Dec. 31, the company had 8.51 million net new subscribers. It ended the period with a total of 203.7 million paid subscriptions, representing a year-over-year increase of 21.9%. Netflix thinks it will add 6 million new subscribers in the first quarter of 2021.</p><p>And the streaming services industry as a whole has a long runway for growth. According to Grand View Research, this market was worth 50.1 billion in 2020, and it is projected to expand at a compound annual growth rate (CAGR) of 21% between 2021 and 2028.</p><p>As one of the most recognizable names in this segment, Netflix is well-positioned to profit, especially since competing streaming platforms are more than capable of coexisting. One of the most powerful weapons in these platforms' arsenals is original content, and Netflix has been pouring money into original series and movies in the hopes of building a library people will want to keep coming back to.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F617555%2Fgettyimages-1174414330.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images.</p><p>These investments have played an important role in the company's success in recent years. Since the content on Netflix is different from that of some of its peers,&nbsp;many customers are more than happy to pay for subscriptions to several companies in this space. The long-term plan for Netflix is simple: Replace regular TV.</p><p>The company offers several advantages over cable: no ads, no long-term contracts, and on-demand movies and series streaming on any device. And while some cable providers have started to adapt to the new paradigm, Netflix is well on its way to continue its long winning streak in the streaming industry. Those factors make the company's stock worth a buy.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nForget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-16 23:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/><strong>Prosper Junior Bakiny</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BPOPM":"Popular","BPOPN":"Popular"},"source_url":"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2119619927","content_text":"The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the list of the 100 most popular stocks on the platform. However, some of the stocks on that list are head-scratchers. For instance, GameStop (NYSE:GME) and AMC Entertainment (NYSE:AMC) are among the top 20 most commonly held stocks on the app as of this writing.Both of these businesses are struggling, in part due to their reliance on brick-and-mortar operations, which were severely impacted by the pandemic. Further, both AMC and Gamestop were at the center of the now (in)famous short-squeeze fiasco orchestrated by traders from Reddit's r/WallStreetBets. Investors would be better off staying away from these two unpredictable companies and instead purchasing shares of Robinhood stocks with solid futures ahead of them. Two such companies worth considering are Pfizer (NYSE:PFE) and Netflix (NASDAQ:NFLX).^SPX data by YCharts1. PfizerYou've probably heard a lot about Pfizer in the past few months. The company and its partner, BioNTech, developed BNT162b2, and received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) in December, becoming the first authorized COVID-19 vaccine in the U.S. BNT162b2 has also been approved in the European Union.While Pfizer and BioNTech have to share the vaccine supply gameboard with several other companies, including Johnson & Johnson, AstraZeneca, and Moderna, the market (i.e., the entire world) is large enough for there to be multiple winners. In other words, BNT162b2 will contribute meaningfully to Pfizer's top line, especially since there is evidence of it being effective against some of the newer variants of the virus.But the company's lineup is much bigger than just this one vaccine. Some of Pfizer's top-performing products include anticoagulant Eliquis and cancer treatments Ibrance and Xtandi. Sales of Eliquis for fiscal year 2020 (ended Dec. 31) were $4.9 billion, a 17% year-over-year increase. Ibrance's revenue jumped by 9% year over year to $5.4 billion, while Xtandi's sales came in at roughly $1 billion, representing 22% growth from fiscal year 2019.Pfizer also boasts 95 programs in its pipeline, including 24 ongoing phase 3 studies. Pfizer is well-positioned to keep adding new revenue sources to its lineup every year. Lastly, it is worth noting that Pfizer spun-off its off-patent medicine unit Upjohn to the company formerly known as Mylan. The combined entity of Mylan and Upjohn is called Viatris, and it started trading on the market on Nov. 17.Pfizer decided to make this move because Upjohn's declining sales were hurting its bottom line. The company can now focus on its more profitable biopharma business. This focus should help Pfizer improve its financial results, which will help its stock recover from its underperformance relative to the market in the past year.With a more focused business, a short-term catalyst in the form of its coronavirus vaccine, other medicines with growing sales, and a rich pipeline to keep revenue sources coming, this pharma stock looks like a much better long-term bet than AMC or GameStop.Image source: Getty Images2. NetflixNetflix is already one of the leading streaming video platforms in the world, but the company isn't done growing. What are the opportunities ahead for the tech giant? First, the company is looking to add even more users to its platform. As of its fourth quarter ending Dec. 31, the company had 8.51 million net new subscribers. It ended the period with a total of 203.7 million paid subscriptions, representing a year-over-year increase of 21.9%. Netflix thinks it will add 6 million new subscribers in the first quarter of 2021.And the streaming services industry as a whole has a long runway for growth. According to Grand View Research, this market was worth 50.1 billion in 2020, and it is projected to expand at a compound annual growth rate (CAGR) of 21% between 2021 and 2028.As one of the most recognizable names in this segment, Netflix is well-positioned to profit, especially since competing streaming platforms are more than capable of coexisting. One of the most powerful weapons in these platforms' arsenals is original content, and Netflix has been pouring money into original series and movies in the hopes of building a library people will want to keep coming back to.Image source: Getty Images.These investments have played an important role in the company's success in recent years. Since the content on Netflix is different from that of some of its peers, many customers are more than happy to pay for subscriptions to several companies in this space. The long-term plan for Netflix is simple: Replace regular TV.The company offers several advantages over cable: no ads, no long-term contracts, and on-demand movies and series streaming on any device. And while some cable providers have started to adapt to the new paradigm, Netflix is well on its way to continue its long winning streak in the streaming industry. Those factors make the company's stock worth a buy.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":324097328,"gmtCreate":1615942337464,"gmtModify":1703495278364,"author":{"id":"3559297454639767","authorId":"3559297454639767","name":"MJ2317","avatar":"https://static.tigerbbs.com/e630b11b8aefdaa3f6d659668006e6c9","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/324097328","repostId":2119619927,"repostType":4,"repost":{"id":"2119619927","pubTimestamp":1615907700,"share":"https://www.laohu8.com/m/news/2119619927?lang=&edition=full","pubTime":"2021-03-16 23:15","market":"us","language":"en","title":"Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys","url":"https://stock-news.laohu8.com/highlight/detail?id=2119619927","media":"Prosper Junior Bakiny","summary":"No need to invest in faltering businesses -- these two winning companies are better bets.","content":"<p>The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the list of the 100 most popular stocks on the platform. However, some of the stocks on that list are head-scratchers. For instance, <b>GameStop</b> (NYSE:GME) and <b>AMC Entertainment</b> (NYSE:AMC) are among the top 20 most commonly held stocks on the app as of this writing.</p><p>Both of these businesses are struggling, in part due to their reliance on brick-and-mortar operations, which were severely impacted by the pandemic. Further, both AMC and Gamestop were at the center of the now (in)famous short-squeeze fiasco orchestrated by traders from Reddit's r/WallStreetBets. Investors would be better off staying away from these two unpredictable companies and instead purchasing shares of Robinhood stocks with solid futures ahead of them. Two such companies worth considering are <b>Pfizer</b> (NYSE:PFE) and <b>Netflix</b> (NASDAQ:NFLX).</p><p><img src=\"https://media.ycharts.com/charts/693c6b3570e5dc157db6f1cb5d80481e.png\" tg-width=\"720\" tg-height=\"387\" referrerpolicy=\"no-referrer\"></p><p>^SPX data by YCharts</p><p><b>1. Pfizer</b></p><p>You've probably heard a lot about Pfizer in the past few months. The company and its partner, <b>BioNTech</b>, developed BNT162b2, and received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) in December, becoming the first authorized COVID-19 vaccine in the U.S. BNT162b2 has also been approved in the European Union.</p><p>While Pfizer and BioNTech have to share the vaccine supply gameboard with several other companies, including <b>Johnson &amp; Johnson</b>, <b>AstraZeneca</b>, and <b>Moderna</b>, the market (i.e., the entire world) is large enough for there to be multiple winners. In other words, BNT162b2 will contribute meaningfully to Pfizer's top line, especially since there is evidence of it being effective against some of the newer variants of the virus.</p><p>But the company's lineup is much bigger than just this <a href=\"https://laohu8.com/S/AONE\">one</a> vaccine. Some of Pfizer's top-performing products include anticoagulant Eliquis and cancer treatments Ibrance and Xtandi. Sales of Eliquis for fiscal year 2020 (ended Dec. 31) were $4.9 billion, a 17% year-over-year increase. Ibrance's revenue jumped by 9% year over year to $5.4 billion, while Xtandi's sales came in at roughly $1 billion, representing 22% growth from fiscal year 2019.</p><p>Pfizer also boasts 95 programs in its pipeline, including 24 ongoing phase 3 studies. Pfizer is well-positioned to keep adding new revenue sources to its lineup every year. Lastly, it is worth noting that Pfizer spun-off its off-patent medicine unit Upjohn to the company formerly known as Mylan. The combined entity of Mylan and Upjohn is called <b>Viatris</b>, and it started trading on the market on Nov. 17.</p><p>Pfizer decided to make this move because Upjohn's declining sales were hurting its bottom line. The company can now focus on its more profitable biopharma business. This focus should help Pfizer improve its financial results, which will help its stock recover from its underperformance relative to the market in the past year.</p><p>With a more focused business, a short-term catalyst in the form of its coronavirus vaccine, other medicines with growing sales, and a rich pipeline to keep revenue sources coming, this pharma stock looks like a much better long-term bet than AMC or GameStop.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F617555%2Fgettyimages-1291715271.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images</p><p><b>2. Netflix</b></p><p>Netflix is already <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leading streaming video platforms in the world, but the company isn't done growing. What are the opportunities ahead for the tech giant? First, the company is looking to add even more users to its platform. As of its fourth quarter ending Dec. 31, the company had 8.51 million net new subscribers. It ended the period with a total of 203.7 million paid subscriptions, representing a year-over-year increase of 21.9%. Netflix thinks it will add 6 million new subscribers in the first quarter of 2021.</p><p>And the streaming services industry as a whole has a long runway for growth. According to Grand View Research, this market was worth 50.1 billion in 2020, and it is projected to expand at a compound annual growth rate (CAGR) of 21% between 2021 and 2028.</p><p>As one of the most recognizable names in this segment, Netflix is well-positioned to profit, especially since competing streaming platforms are more than capable of coexisting. One of the most powerful weapons in these platforms' arsenals is original content, and Netflix has been pouring money into original series and movies in the hopes of building a library people will want to keep coming back to.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F617555%2Fgettyimages-1174414330.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images.</p><p>These investments have played an important role in the company's success in recent years. Since the content on Netflix is different from that of some of its peers,&nbsp;many customers are more than happy to pay for subscriptions to several companies in this space. The long-term plan for Netflix is simple: Replace regular TV.</p><p>The company offers several advantages over cable: no ads, no long-term contracts, and on-demand movies and series streaming on any device. And while some cable providers have started to adapt to the new paradigm, Netflix is well on its way to continue its long winning streak in the streaming industry. Those factors make the company's stock worth a buy.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nForget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-16 23:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/><strong>Prosper Junior Bakiny</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BPOPM":"Popular","BPOPN":"Popular"},"source_url":"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2119619927","content_text":"The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the list of the 100 most popular stocks on the platform. However, some of the stocks on that list are head-scratchers. For instance, GameStop (NYSE:GME) and AMC Entertainment (NYSE:AMC) are among the top 20 most commonly held stocks on the app as of this writing.Both of these businesses are struggling, in part due to their reliance on brick-and-mortar operations, which were severely impacted by the pandemic. Further, both AMC and Gamestop were at the center of the now (in)famous short-squeeze fiasco orchestrated by traders from Reddit's r/WallStreetBets. Investors would be better off staying away from these two unpredictable companies and instead purchasing shares of Robinhood stocks with solid futures ahead of them. Two such companies worth considering are Pfizer (NYSE:PFE) and Netflix (NASDAQ:NFLX).^SPX data by YCharts1. PfizerYou've probably heard a lot about Pfizer in the past few months. The company and its partner, BioNTech, developed BNT162b2, and received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) in December, becoming the first authorized COVID-19 vaccine in the U.S. BNT162b2 has also been approved in the European Union.While Pfizer and BioNTech have to share the vaccine supply gameboard with several other companies, including Johnson & Johnson, AstraZeneca, and Moderna, the market (i.e., the entire world) is large enough for there to be multiple winners. In other words, BNT162b2 will contribute meaningfully to Pfizer's top line, especially since there is evidence of it being effective against some of the newer variants of the virus.But the company's lineup is much bigger than just this one vaccine. Some of Pfizer's top-performing products include anticoagulant Eliquis and cancer treatments Ibrance and Xtandi. Sales of Eliquis for fiscal year 2020 (ended Dec. 31) were $4.9 billion, a 17% year-over-year increase. Ibrance's revenue jumped by 9% year over year to $5.4 billion, while Xtandi's sales came in at roughly $1 billion, representing 22% growth from fiscal year 2019.Pfizer also boasts 95 programs in its pipeline, including 24 ongoing phase 3 studies. Pfizer is well-positioned to keep adding new revenue sources to its lineup every year. Lastly, it is worth noting that Pfizer spun-off its off-patent medicine unit Upjohn to the company formerly known as Mylan. The combined entity of Mylan and Upjohn is called Viatris, and it started trading on the market on Nov. 17.Pfizer decided to make this move because Upjohn's declining sales were hurting its bottom line. The company can now focus on its more profitable biopharma business. This focus should help Pfizer improve its financial results, which will help its stock recover from its underperformance relative to the market in the past year.With a more focused business, a short-term catalyst in the form of its coronavirus vaccine, other medicines with growing sales, and a rich pipeline to keep revenue sources coming, this pharma stock looks like a much better long-term bet than AMC or GameStop.Image source: Getty Images2. NetflixNetflix is already one of the leading streaming video platforms in the world, but the company isn't done growing. What are the opportunities ahead for the tech giant? First, the company is looking to add even more users to its platform. As of its fourth quarter ending Dec. 31, the company had 8.51 million net new subscribers. It ended the period with a total of 203.7 million paid subscriptions, representing a year-over-year increase of 21.9%. Netflix thinks it will add 6 million new subscribers in the first quarter of 2021.And the streaming services industry as a whole has a long runway for growth. According to Grand View Research, this market was worth 50.1 billion in 2020, and it is projected to expand at a compound annual growth rate (CAGR) of 21% between 2021 and 2028.As one of the most recognizable names in this segment, Netflix is well-positioned to profit, especially since competing streaming platforms are more than capable of coexisting. One of the most powerful weapons in these platforms' arsenals is original content, and Netflix has been pouring money into original series and movies in the hopes of building a library people will want to keep coming back to.Image source: Getty Images.These investments have played an important role in the company's success in recent years. Since the content on Netflix is different from that of some of its peers, many customers are more than happy to pay for subscriptions to several companies in this space. The long-term plan for Netflix is simple: Replace regular TV.The company offers several advantages over cable: no ads, no long-term contracts, and on-demand movies and series streaming on any device. And while some cable providers have started to adapt to the new paradigm, Netflix is well on its way to continue its long winning streak in the streaming industry. Those factors make the company's stock worth a buy.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":324007868,"gmtCreate":1615941710854,"gmtModify":1703495262073,"author":{"id":"3561088065415396","authorId":"3561088065415396","name":"henryee18","avatar":"https://static.tigerbbs.com/68e1124a4989ce380d6aa143a07b2620","vip":1,"crmLevel":8,"crmLevelSwitch":0},"htmlText":"Dang, the stocks raise too quick.","listText":"Dang, the stocks raise too quick.","text":"Dang, the stocks raise too quick.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/324007868","repostId":2119619927,"repostType":4,"repost":{"id":"2119619927","pubTimestamp":1615907700,"share":"https://www.laohu8.com/m/news/2119619927?lang=&edition=full","pubTime":"2021-03-16 23:15","market":"us","language":"en","title":"Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys","url":"https://stock-news.laohu8.com/highlight/detail?id=2119619927","media":"Prosper Junior Bakiny","summary":"No need to invest in faltering businesses -- these two winning companies are better bets.","content":"<p>The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the list of the 100 most popular stocks on the platform. However, some of the stocks on that list are head-scratchers. For instance, <b>GameStop</b> (NYSE:GME) and <b>AMC Entertainment</b> (NYSE:AMC) are among the top 20 most commonly held stocks on the app as of this writing.</p><p>Both of these businesses are struggling, in part due to their reliance on brick-and-mortar operations, which were severely impacted by the pandemic. Further, both AMC and Gamestop were at the center of the now (in)famous short-squeeze fiasco orchestrated by traders from Reddit's r/WallStreetBets. Investors would be better off staying away from these two unpredictable companies and instead purchasing shares of Robinhood stocks with solid futures ahead of them. Two such companies worth considering are <b>Pfizer</b> (NYSE:PFE) and <b>Netflix</b> (NASDAQ:NFLX).</p><p><img src=\"https://media.ycharts.com/charts/693c6b3570e5dc157db6f1cb5d80481e.png\" tg-width=\"720\" tg-height=\"387\" referrerpolicy=\"no-referrer\"></p><p>^SPX data by YCharts</p><p><b>1. Pfizer</b></p><p>You've probably heard a lot about Pfizer in the past few months. The company and its partner, <b>BioNTech</b>, developed BNT162b2, and received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) in December, becoming the first authorized COVID-19 vaccine in the U.S. BNT162b2 has also been approved in the European Union.</p><p>While Pfizer and BioNTech have to share the vaccine supply gameboard with several other companies, including <b>Johnson &amp; Johnson</b>, <b>AstraZeneca</b>, and <b>Moderna</b>, the market (i.e., the entire world) is large enough for there to be multiple winners. In other words, BNT162b2 will contribute meaningfully to Pfizer's top line, especially since there is evidence of it being effective against some of the newer variants of the virus.</p><p>But the company's lineup is much bigger than just this <a href=\"https://laohu8.com/S/AONE\">one</a> vaccine. Some of Pfizer's top-performing products include anticoagulant Eliquis and cancer treatments Ibrance and Xtandi. Sales of Eliquis for fiscal year 2020 (ended Dec. 31) were $4.9 billion, a 17% year-over-year increase. Ibrance's revenue jumped by 9% year over year to $5.4 billion, while Xtandi's sales came in at roughly $1 billion, representing 22% growth from fiscal year 2019.</p><p>Pfizer also boasts 95 programs in its pipeline, including 24 ongoing phase 3 studies. Pfizer is well-positioned to keep adding new revenue sources to its lineup every year. Lastly, it is worth noting that Pfizer spun-off its off-patent medicine unit Upjohn to the company formerly known as Mylan. The combined entity of Mylan and Upjohn is called <b>Viatris</b>, and it started trading on the market on Nov. 17.</p><p>Pfizer decided to make this move because Upjohn's declining sales were hurting its bottom line. The company can now focus on its more profitable biopharma business. This focus should help Pfizer improve its financial results, which will help its stock recover from its underperformance relative to the market in the past year.</p><p>With a more focused business, a short-term catalyst in the form of its coronavirus vaccine, other medicines with growing sales, and a rich pipeline to keep revenue sources coming, this pharma stock looks like a much better long-term bet than AMC or GameStop.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F617555%2Fgettyimages-1291715271.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images</p><p><b>2. Netflix</b></p><p>Netflix is already <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leading streaming video platforms in the world, but the company isn't done growing. What are the opportunities ahead for the tech giant? First, the company is looking to add even more users to its platform. As of its fourth quarter ending Dec. 31, the company had 8.51 million net new subscribers. It ended the period with a total of 203.7 million paid subscriptions, representing a year-over-year increase of 21.9%. Netflix thinks it will add 6 million new subscribers in the first quarter of 2021.</p><p>And the streaming services industry as a whole has a long runway for growth. According to Grand View Research, this market was worth 50.1 billion in 2020, and it is projected to expand at a compound annual growth rate (CAGR) of 21% between 2021 and 2028.</p><p>As one of the most recognizable names in this segment, Netflix is well-positioned to profit, especially since competing streaming platforms are more than capable of coexisting. One of the most powerful weapons in these platforms' arsenals is original content, and Netflix has been pouring money into original series and movies in the hopes of building a library people will want to keep coming back to.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F617555%2Fgettyimages-1174414330.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images.</p><p>These investments have played an important role in the company's success in recent years. Since the content on Netflix is different from that of some of its peers,&nbsp;many customers are more than happy to pay for subscriptions to several companies in this space. The long-term plan for Netflix is simple: Replace regular TV.</p><p>The company offers several advantages over cable: no ads, no long-term contracts, and on-demand movies and series streaming on any device. And while some cable providers have started to adapt to the new paradigm, Netflix is well on its way to continue its long winning streak in the streaming industry. Those factors make the company's stock worth a buy.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nForget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-16 23:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/><strong>Prosper Junior Bakiny</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BPOPM":"Popular","BPOPN":"Popular"},"source_url":"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2119619927","content_text":"The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the list of the 100 most popular stocks on the platform. However, some of the stocks on that list are head-scratchers. For instance, GameStop (NYSE:GME) and AMC Entertainment (NYSE:AMC) are among the top 20 most commonly held stocks on the app as of this writing.Both of these businesses are struggling, in part due to their reliance on brick-and-mortar operations, which were severely impacted by the pandemic. Further, both AMC and Gamestop were at the center of the now (in)famous short-squeeze fiasco orchestrated by traders from Reddit's r/WallStreetBets. Investors would be better off staying away from these two unpredictable companies and instead purchasing shares of Robinhood stocks with solid futures ahead of them. Two such companies worth considering are Pfizer (NYSE:PFE) and Netflix (NASDAQ:NFLX).^SPX data by YCharts1. PfizerYou've probably heard a lot about Pfizer in the past few months. The company and its partner, BioNTech, developed BNT162b2, and received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) in December, becoming the first authorized COVID-19 vaccine in the U.S. BNT162b2 has also been approved in the European Union.While Pfizer and BioNTech have to share the vaccine supply gameboard with several other companies, including Johnson & Johnson, AstraZeneca, and Moderna, the market (i.e., the entire world) is large enough for there to be multiple winners. In other words, BNT162b2 will contribute meaningfully to Pfizer's top line, especially since there is evidence of it being effective against some of the newer variants of the virus.But the company's lineup is much bigger than just this one vaccine. Some of Pfizer's top-performing products include anticoagulant Eliquis and cancer treatments Ibrance and Xtandi. Sales of Eliquis for fiscal year 2020 (ended Dec. 31) were $4.9 billion, a 17% year-over-year increase. Ibrance's revenue jumped by 9% year over year to $5.4 billion, while Xtandi's sales came in at roughly $1 billion, representing 22% growth from fiscal year 2019.Pfizer also boasts 95 programs in its pipeline, including 24 ongoing phase 3 studies. Pfizer is well-positioned to keep adding new revenue sources to its lineup every year. Lastly, it is worth noting that Pfizer spun-off its off-patent medicine unit Upjohn to the company formerly known as Mylan. The combined entity of Mylan and Upjohn is called Viatris, and it started trading on the market on Nov. 17.Pfizer decided to make this move because Upjohn's declining sales were hurting its bottom line. The company can now focus on its more profitable biopharma business. This focus should help Pfizer improve its financial results, which will help its stock recover from its underperformance relative to the market in the past year.With a more focused business, a short-term catalyst in the form of its coronavirus vaccine, other medicines with growing sales, and a rich pipeline to keep revenue sources coming, this pharma stock looks like a much better long-term bet than AMC or GameStop.Image source: Getty Images2. NetflixNetflix is already one of the leading streaming video platforms in the world, but the company isn't done growing. What are the opportunities ahead for the tech giant? First, the company is looking to add even more users to its platform. As of its fourth quarter ending Dec. 31, the company had 8.51 million net new subscribers. It ended the period with a total of 203.7 million paid subscriptions, representing a year-over-year increase of 21.9%. Netflix thinks it will add 6 million new subscribers in the first quarter of 2021.And the streaming services industry as a whole has a long runway for growth. According to Grand View Research, this market was worth 50.1 billion in 2020, and it is projected to expand at a compound annual growth rate (CAGR) of 21% between 2021 and 2028.As one of the most recognizable names in this segment, Netflix is well-positioned to profit, especially since competing streaming platforms are more than capable of coexisting. One of the most powerful weapons in these platforms' arsenals is original content, and Netflix has been pouring money into original series and movies in the hopes of building a library people will want to keep coming back to.Image source: Getty Images.These investments have played an important role in the company's success in recent years. Since the content on Netflix is different from that of some of its peers, many customers are more than happy to pay for subscriptions to several companies in this space. The long-term plan for Netflix is simple: Replace regular TV.The company offers several advantages over cable: no ads, no long-term contracts, and on-demand movies and series streaming on any device. And while some cable providers have started to adapt to the new paradigm, Netflix is well on its way to continue its long winning streak in the streaming industry. Those factors make the company's stock worth a buy.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":325746954,"gmtCreate":1615940383178,"gmtModify":1703495225296,"author":{"id":"3577496233814703","authorId":"3577496233814703","name":"pinghu","avatar":"https://static.tigerbbs.com/42c1937c871b61f4912f7e80672da554","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"[财迷]&nbsp;","listText":"[财迷]&nbsp;","text":"[财迷]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/325746954","repostId":2119619927,"repostType":4,"repost":{"id":"2119619927","pubTimestamp":1615907700,"share":"https://www.laohu8.com/m/news/2119619927?lang=&edition=full","pubTime":"2021-03-16 23:15","market":"us","language":"en","title":"Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys","url":"https://stock-news.laohu8.com/highlight/detail?id=2119619927","media":"Prosper Junior Bakiny","summary":"No need to invest in faltering businesses -- these two winning companies are better bets.","content":"<p>The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the list of the 100 most popular stocks on the platform. However, some of the stocks on that list are head-scratchers. For instance, <b>GameStop</b> (NYSE:GME) and <b>AMC Entertainment</b> (NYSE:AMC) are among the top 20 most commonly held stocks on the app as of this writing.</p><p>Both of these businesses are struggling, in part due to their reliance on brick-and-mortar operations, which were severely impacted by the pandemic. Further, both AMC and Gamestop were at the center of the now (in)famous short-squeeze fiasco orchestrated by traders from Reddit's r/WallStreetBets. Investors would be better off staying away from these two unpredictable companies and instead purchasing shares of Robinhood stocks with solid futures ahead of them. Two such companies worth considering are <b>Pfizer</b> (NYSE:PFE) and <b>Netflix</b> (NASDAQ:NFLX).</p><p><img src=\"https://media.ycharts.com/charts/693c6b3570e5dc157db6f1cb5d80481e.png\" tg-width=\"720\" tg-height=\"387\" referrerpolicy=\"no-referrer\"></p><p>^SPX data by YCharts</p><p><b>1. Pfizer</b></p><p>You've probably heard a lot about Pfizer in the past few months. The company and its partner, <b>BioNTech</b>, developed BNT162b2, and received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) in December, becoming the first authorized COVID-19 vaccine in the U.S. BNT162b2 has also been approved in the European Union.</p><p>While Pfizer and BioNTech have to share the vaccine supply gameboard with several other companies, including <b>Johnson &amp; Johnson</b>, <b>AstraZeneca</b>, and <b>Moderna</b>, the market (i.e., the entire world) is large enough for there to be multiple winners. In other words, BNT162b2 will contribute meaningfully to Pfizer's top line, especially since there is evidence of it being effective against some of the newer variants of the virus.</p><p>But the company's lineup is much bigger than just this <a href=\"https://laohu8.com/S/AONE\">one</a> vaccine. Some of Pfizer's top-performing products include anticoagulant Eliquis and cancer treatments Ibrance and Xtandi. Sales of Eliquis for fiscal year 2020 (ended Dec. 31) were $4.9 billion, a 17% year-over-year increase. Ibrance's revenue jumped by 9% year over year to $5.4 billion, while Xtandi's sales came in at roughly $1 billion, representing 22% growth from fiscal year 2019.</p><p>Pfizer also boasts 95 programs in its pipeline, including 24 ongoing phase 3 studies. Pfizer is well-positioned to keep adding new revenue sources to its lineup every year. Lastly, it is worth noting that Pfizer spun-off its off-patent medicine unit Upjohn to the company formerly known as Mylan. The combined entity of Mylan and Upjohn is called <b>Viatris</b>, and it started trading on the market on Nov. 17.</p><p>Pfizer decided to make this move because Upjohn's declining sales were hurting its bottom line. The company can now focus on its more profitable biopharma business. This focus should help Pfizer improve its financial results, which will help its stock recover from its underperformance relative to the market in the past year.</p><p>With a more focused business, a short-term catalyst in the form of its coronavirus vaccine, other medicines with growing sales, and a rich pipeline to keep revenue sources coming, this pharma stock looks like a much better long-term bet than AMC or GameStop.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F617555%2Fgettyimages-1291715271.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images</p><p><b>2. Netflix</b></p><p>Netflix is already <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leading streaming video platforms in the world, but the company isn't done growing. What are the opportunities ahead for the tech giant? First, the company is looking to add even more users to its platform. As of its fourth quarter ending Dec. 31, the company had 8.51 million net new subscribers. It ended the period with a total of 203.7 million paid subscriptions, representing a year-over-year increase of 21.9%. Netflix thinks it will add 6 million new subscribers in the first quarter of 2021.</p><p>And the streaming services industry as a whole has a long runway for growth. According to Grand View Research, this market was worth 50.1 billion in 2020, and it is projected to expand at a compound annual growth rate (CAGR) of 21% between 2021 and 2028.</p><p>As one of the most recognizable names in this segment, Netflix is well-positioned to profit, especially since competing streaming platforms are more than capable of coexisting. One of the most powerful weapons in these platforms' arsenals is original content, and Netflix has been pouring money into original series and movies in the hopes of building a library people will want to keep coming back to.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F617555%2Fgettyimages-1174414330.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images.</p><p>These investments have played an important role in the company's success in recent years. Since the content on Netflix is different from that of some of its peers,&nbsp;many customers are more than happy to pay for subscriptions to several companies in this space. The long-term plan for Netflix is simple: Replace regular TV.</p><p>The company offers several advantages over cable: no ads, no long-term contracts, and on-demand movies and series streaming on any device. And while some cable providers have started to adapt to the new paradigm, Netflix is well on its way to continue its long winning streak in the streaming industry. Those factors make the company's stock worth a buy.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nForget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-16 23:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/><strong>Prosper Junior Bakiny</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BPOPM":"Popular","BPOPN":"Popular"},"source_url":"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2119619927","content_text":"The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the list of the 100 most popular stocks on the platform. However, some of the stocks on that list are head-scratchers. For instance, GameStop (NYSE:GME) and AMC Entertainment (NYSE:AMC) are among the top 20 most commonly held stocks on the app as of this writing.Both of these businesses are struggling, in part due to their reliance on brick-and-mortar operations, which were severely impacted by the pandemic. Further, both AMC and Gamestop were at the center of the now (in)famous short-squeeze fiasco orchestrated by traders from Reddit's r/WallStreetBets. Investors would be better off staying away from these two unpredictable companies and instead purchasing shares of Robinhood stocks with solid futures ahead of them. Two such companies worth considering are Pfizer (NYSE:PFE) and Netflix (NASDAQ:NFLX).^SPX data by YCharts1. PfizerYou've probably heard a lot about Pfizer in the past few months. The company and its partner, BioNTech, developed BNT162b2, and received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) in December, becoming the first authorized COVID-19 vaccine in the U.S. BNT162b2 has also been approved in the European Union.While Pfizer and BioNTech have to share the vaccine supply gameboard with several other companies, including Johnson & Johnson, AstraZeneca, and Moderna, the market (i.e., the entire world) is large enough for there to be multiple winners. In other words, BNT162b2 will contribute meaningfully to Pfizer's top line, especially since there is evidence of it being effective against some of the newer variants of the virus.But the company's lineup is much bigger than just this one vaccine. Some of Pfizer's top-performing products include anticoagulant Eliquis and cancer treatments Ibrance and Xtandi. Sales of Eliquis for fiscal year 2020 (ended Dec. 31) were $4.9 billion, a 17% year-over-year increase. Ibrance's revenue jumped by 9% year over year to $5.4 billion, while Xtandi's sales came in at roughly $1 billion, representing 22% growth from fiscal year 2019.Pfizer also boasts 95 programs in its pipeline, including 24 ongoing phase 3 studies. Pfizer is well-positioned to keep adding new revenue sources to its lineup every year. Lastly, it is worth noting that Pfizer spun-off its off-patent medicine unit Upjohn to the company formerly known as Mylan. The combined entity of Mylan and Upjohn is called Viatris, and it started trading on the market on Nov. 17.Pfizer decided to make this move because Upjohn's declining sales were hurting its bottom line. The company can now focus on its more profitable biopharma business. This focus should help Pfizer improve its financial results, which will help its stock recover from its underperformance relative to the market in the past year.With a more focused business, a short-term catalyst in the form of its coronavirus vaccine, other medicines with growing sales, and a rich pipeline to keep revenue sources coming, this pharma stock looks like a much better long-term bet than AMC or GameStop.Image source: Getty Images2. NetflixNetflix is already one of the leading streaming video platforms in the world, but the company isn't done growing. What are the opportunities ahead for the tech giant? First, the company is looking to add even more users to its platform. As of its fourth quarter ending Dec. 31, the company had 8.51 million net new subscribers. It ended the period with a total of 203.7 million paid subscriptions, representing a year-over-year increase of 21.9%. Netflix thinks it will add 6 million new subscribers in the first quarter of 2021.And the streaming services industry as a whole has a long runway for growth. According to Grand View Research, this market was worth 50.1 billion in 2020, and it is projected to expand at a compound annual growth rate (CAGR) of 21% between 2021 and 2028.As one of the most recognizable names in this segment, Netflix is well-positioned to profit, especially since competing streaming platforms are more than capable of coexisting. One of the most powerful weapons in these platforms' arsenals is original content, and Netflix has been pouring money into original series and movies in the hopes of building a library people will want to keep coming back to.Image source: Getty Images.These investments have played an important role in the company's success in recent years. Since the content on Netflix is different from that of some of its peers, many customers are more than happy to pay for subscriptions to several companies in this space. The long-term plan for Netflix is simple: Replace regular TV.The company offers several advantages over cable: no ads, no long-term contracts, and on-demand movies and series streaming on any device. And while some cable providers have started to adapt to the new paradigm, Netflix is well on its way to continue its long winning streak in the streaming industry. Those factors make the company's stock worth a buy.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":325756661,"gmtCreate":1615939837653,"gmtModify":1703495211855,"author":{"id":"3578558472894517","authorId":"3578558472894517","name":"Kayabunz","avatar":"https://static.tigerbbs.com/f55b83d8dfc7c9f14a1d8b86e9727914","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Vaccines vaccines","listText":"Vaccines vaccines","text":"Vaccines vaccines","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/325756661","repostId":2119619927,"repostType":4,"repost":{"id":"2119619927","pubTimestamp":1615907700,"share":"https://www.laohu8.com/m/news/2119619927?lang=&edition=full","pubTime":"2021-03-16 23:15","market":"us","language":"en","title":"Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys","url":"https://stock-news.laohu8.com/highlight/detail?id=2119619927","media":"Prosper Junior Bakiny","summary":"No need to invest in faltering businesses -- these two winning companies are better bets.","content":"<p>The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the list of the 100 most popular stocks on the platform. However, some of the stocks on that list are head-scratchers. For instance, <b>GameStop</b> (NYSE:GME) and <b>AMC Entertainment</b> (NYSE:AMC) are among the top 20 most commonly held stocks on the app as of this writing.</p><p>Both of these businesses are struggling, in part due to their reliance on brick-and-mortar operations, which were severely impacted by the pandemic. Further, both AMC and Gamestop were at the center of the now (in)famous short-squeeze fiasco orchestrated by traders from Reddit's r/WallStreetBets. Investors would be better off staying away from these two unpredictable companies and instead purchasing shares of Robinhood stocks with solid futures ahead of them. Two such companies worth considering are <b>Pfizer</b> (NYSE:PFE) and <b>Netflix</b> (NASDAQ:NFLX).</p><p><img src=\"https://media.ycharts.com/charts/693c6b3570e5dc157db6f1cb5d80481e.png\" tg-width=\"720\" tg-height=\"387\" referrerpolicy=\"no-referrer\"></p><p>^SPX data by YCharts</p><p><b>1. Pfizer</b></p><p>You've probably heard a lot about Pfizer in the past few months. The company and its partner, <b>BioNTech</b>, developed BNT162b2, and received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) in December, becoming the first authorized COVID-19 vaccine in the U.S. BNT162b2 has also been approved in the European Union.</p><p>While Pfizer and BioNTech have to share the vaccine supply gameboard with several other companies, including <b>Johnson &amp; Johnson</b>, <b>AstraZeneca</b>, and <b>Moderna</b>, the market (i.e., the entire world) is large enough for there to be multiple winners. In other words, BNT162b2 will contribute meaningfully to Pfizer's top line, especially since there is evidence of it being effective against some of the newer variants of the virus.</p><p>But the company's lineup is much bigger than just this <a href=\"https://laohu8.com/S/AONE\">one</a> vaccine. Some of Pfizer's top-performing products include anticoagulant Eliquis and cancer treatments Ibrance and Xtandi. Sales of Eliquis for fiscal year 2020 (ended Dec. 31) were $4.9 billion, a 17% year-over-year increase. Ibrance's revenue jumped by 9% year over year to $5.4 billion, while Xtandi's sales came in at roughly $1 billion, representing 22% growth from fiscal year 2019.</p><p>Pfizer also boasts 95 programs in its pipeline, including 24 ongoing phase 3 studies. Pfizer is well-positioned to keep adding new revenue sources to its lineup every year. Lastly, it is worth noting that Pfizer spun-off its off-patent medicine unit Upjohn to the company formerly known as Mylan. The combined entity of Mylan and Upjohn is called <b>Viatris</b>, and it started trading on the market on Nov. 17.</p><p>Pfizer decided to make this move because Upjohn's declining sales were hurting its bottom line. The company can now focus on its more profitable biopharma business. This focus should help Pfizer improve its financial results, which will help its stock recover from its underperformance relative to the market in the past year.</p><p>With a more focused business, a short-term catalyst in the form of its coronavirus vaccine, other medicines with growing sales, and a rich pipeline to keep revenue sources coming, this pharma stock looks like a much better long-term bet than AMC or GameStop.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F617555%2Fgettyimages-1291715271.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images</p><p><b>2. Netflix</b></p><p>Netflix is already <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leading streaming video platforms in the world, but the company isn't done growing. What are the opportunities ahead for the tech giant? First, the company is looking to add even more users to its platform. As of its fourth quarter ending Dec. 31, the company had 8.51 million net new subscribers. It ended the period with a total of 203.7 million paid subscriptions, representing a year-over-year increase of 21.9%. Netflix thinks it will add 6 million new subscribers in the first quarter of 2021.</p><p>And the streaming services industry as a whole has a long runway for growth. According to Grand View Research, this market was worth 50.1 billion in 2020, and it is projected to expand at a compound annual growth rate (CAGR) of 21% between 2021 and 2028.</p><p>As one of the most recognizable names in this segment, Netflix is well-positioned to profit, especially since competing streaming platforms are more than capable of coexisting. One of the most powerful weapons in these platforms' arsenals is original content, and Netflix has been pouring money into original series and movies in the hopes of building a library people will want to keep coming back to.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F617555%2Fgettyimages-1174414330.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images.</p><p>These investments have played an important role in the company's success in recent years. Since the content on Netflix is different from that of some of its peers,&nbsp;many customers are more than happy to pay for subscriptions to several companies in this space. The long-term plan for Netflix is simple: Replace regular TV.</p><p>The company offers several advantages over cable: no ads, no long-term contracts, and on-demand movies and series streaming on any device. And while some cable providers have started to adapt to the new paradigm, Netflix is well on its way to continue its long winning streak in the streaming industry. Those factors make the company's stock worth a buy.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nForget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-16 23:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/><strong>Prosper Junior Bakiny</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BPOPM":"Popular","BPOPN":"Popular"},"source_url":"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2119619927","content_text":"The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the list of the 100 most popular stocks on the platform. However, some of the stocks on that list are head-scratchers. For instance, GameStop (NYSE:GME) and AMC Entertainment (NYSE:AMC) are among the top 20 most commonly held stocks on the app as of this writing.Both of these businesses are struggling, in part due to their reliance on brick-and-mortar operations, which were severely impacted by the pandemic. Further, both AMC and Gamestop were at the center of the now (in)famous short-squeeze fiasco orchestrated by traders from Reddit's r/WallStreetBets. Investors would be better off staying away from these two unpredictable companies and instead purchasing shares of Robinhood stocks with solid futures ahead of them. Two such companies worth considering are Pfizer (NYSE:PFE) and Netflix (NASDAQ:NFLX).^SPX data by YCharts1. PfizerYou've probably heard a lot about Pfizer in the past few months. The company and its partner, BioNTech, developed BNT162b2, and received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) in December, becoming the first authorized COVID-19 vaccine in the U.S. BNT162b2 has also been approved in the European Union.While Pfizer and BioNTech have to share the vaccine supply gameboard with several other companies, including Johnson & Johnson, AstraZeneca, and Moderna, the market (i.e., the entire world) is large enough for there to be multiple winners. In other words, BNT162b2 will contribute meaningfully to Pfizer's top line, especially since there is evidence of it being effective against some of the newer variants of the virus.But the company's lineup is much bigger than just this one vaccine. Some of Pfizer's top-performing products include anticoagulant Eliquis and cancer treatments Ibrance and Xtandi. Sales of Eliquis for fiscal year 2020 (ended Dec. 31) were $4.9 billion, a 17% year-over-year increase. Ibrance's revenue jumped by 9% year over year to $5.4 billion, while Xtandi's sales came in at roughly $1 billion, representing 22% growth from fiscal year 2019.Pfizer also boasts 95 programs in its pipeline, including 24 ongoing phase 3 studies. Pfizer is well-positioned to keep adding new revenue sources to its lineup every year. Lastly, it is worth noting that Pfizer spun-off its off-patent medicine unit Upjohn to the company formerly known as Mylan. The combined entity of Mylan and Upjohn is called Viatris, and it started trading on the market on Nov. 17.Pfizer decided to make this move because Upjohn's declining sales were hurting its bottom line. The company can now focus on its more profitable biopharma business. This focus should help Pfizer improve its financial results, which will help its stock recover from its underperformance relative to the market in the past year.With a more focused business, a short-term catalyst in the form of its coronavirus vaccine, other medicines with growing sales, and a rich pipeline to keep revenue sources coming, this pharma stock looks like a much better long-term bet than AMC or GameStop.Image source: Getty Images2. NetflixNetflix is already one of the leading streaming video platforms in the world, but the company isn't done growing. What are the opportunities ahead for the tech giant? First, the company is looking to add even more users to its platform. As of its fourth quarter ending Dec. 31, the company had 8.51 million net new subscribers. It ended the period with a total of 203.7 million paid subscriptions, representing a year-over-year increase of 21.9%. Netflix thinks it will add 6 million new subscribers in the first quarter of 2021.And the streaming services industry as a whole has a long runway for growth. According to Grand View Research, this market was worth 50.1 billion in 2020, and it is projected to expand at a compound annual growth rate (CAGR) of 21% between 2021 and 2028.As one of the most recognizable names in this segment, Netflix is well-positioned to profit, especially since competing streaming platforms are more than capable of coexisting. One of the most powerful weapons in these platforms' arsenals is original content, and Netflix has been pouring money into original series and movies in the hopes of building a library people will want to keep coming back to.Image source: Getty Images.These investments have played an important role in the company's success in recent years. Since the content on Netflix is different from that of some of its peers, many customers are more than happy to pay for subscriptions to several companies in this space. The long-term plan for Netflix is simple: Replace regular TV.The company offers several advantages over cable: no ads, no long-term contracts, and on-demand movies and series streaming on any device. And while some cable providers have started to adapt to the new paradigm, Netflix is well on its way to continue its long winning streak in the streaming industry. Those factors make the company's stock worth a buy.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":325729987,"gmtCreate":1615938873249,"gmtModify":1703495189844,"author":{"id":"3573460279780916","authorId":"3573460279780916","name":"Yyangyang","avatar":"https://static.tigerbbs.com/af03e90f03996b1e2424f9ab150e255a","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"Read.","listText":"Read.","text":"Read.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/325729987","repostId":2119619927,"repostType":4,"repost":{"id":"2119619927","pubTimestamp":1615907700,"share":"https://www.laohu8.com/m/news/2119619927?lang=&edition=full","pubTime":"2021-03-16 23:15","market":"us","language":"en","title":"Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys","url":"https://stock-news.laohu8.com/highlight/detail?id=2119619927","media":"Prosper Junior Bakiny","summary":"No need to invest in faltering businesses -- these two winning companies are better bets.","content":"<p>The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the list of the 100 most popular stocks on the platform. However, some of the stocks on that list are head-scratchers. For instance, <b>GameStop</b> (NYSE:GME) and <b>AMC Entertainment</b> (NYSE:AMC) are among the top 20 most commonly held stocks on the app as of this writing.</p><p>Both of these businesses are struggling, in part due to their reliance on brick-and-mortar operations, which were severely impacted by the pandemic. Further, both AMC and Gamestop were at the center of the now (in)famous short-squeeze fiasco orchestrated by traders from Reddit's r/WallStreetBets. Investors would be better off staying away from these two unpredictable companies and instead purchasing shares of Robinhood stocks with solid futures ahead of them. Two such companies worth considering are <b>Pfizer</b> (NYSE:PFE) and <b>Netflix</b> (NASDAQ:NFLX).</p><p><img src=\"https://media.ycharts.com/charts/693c6b3570e5dc157db6f1cb5d80481e.png\" tg-width=\"720\" tg-height=\"387\" referrerpolicy=\"no-referrer\"></p><p>^SPX data by YCharts</p><p><b>1. Pfizer</b></p><p>You've probably heard a lot about Pfizer in the past few months. The company and its partner, <b>BioNTech</b>, developed BNT162b2, and received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) in December, becoming the first authorized COVID-19 vaccine in the U.S. BNT162b2 has also been approved in the European Union.</p><p>While Pfizer and BioNTech have to share the vaccine supply gameboard with several other companies, including <b>Johnson &amp; Johnson</b>, <b>AstraZeneca</b>, and <b>Moderna</b>, the market (i.e., the entire world) is large enough for there to be multiple winners. In other words, BNT162b2 will contribute meaningfully to Pfizer's top line, especially since there is evidence of it being effective against some of the newer variants of the virus.</p><p>But the company's lineup is much bigger than just this <a href=\"https://laohu8.com/S/AONE\">one</a> vaccine. Some of Pfizer's top-performing products include anticoagulant Eliquis and cancer treatments Ibrance and Xtandi. Sales of Eliquis for fiscal year 2020 (ended Dec. 31) were $4.9 billion, a 17% year-over-year increase. Ibrance's revenue jumped by 9% year over year to $5.4 billion, while Xtandi's sales came in at roughly $1 billion, representing 22% growth from fiscal year 2019.</p><p>Pfizer also boasts 95 programs in its pipeline, including 24 ongoing phase 3 studies. Pfizer is well-positioned to keep adding new revenue sources to its lineup every year. Lastly, it is worth noting that Pfizer spun-off its off-patent medicine unit Upjohn to the company formerly known as Mylan. The combined entity of Mylan and Upjohn is called <b>Viatris</b>, and it started trading on the market on Nov. 17.</p><p>Pfizer decided to make this move because Upjohn's declining sales were hurting its bottom line. The company can now focus on its more profitable biopharma business. This focus should help Pfizer improve its financial results, which will help its stock recover from its underperformance relative to the market in the past year.</p><p>With a more focused business, a short-term catalyst in the form of its coronavirus vaccine, other medicines with growing sales, and a rich pipeline to keep revenue sources coming, this pharma stock looks like a much better long-term bet than AMC or GameStop.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F617555%2Fgettyimages-1291715271.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images</p><p><b>2. Netflix</b></p><p>Netflix is already <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leading streaming video platforms in the world, but the company isn't done growing. What are the opportunities ahead for the tech giant? First, the company is looking to add even more users to its platform. As of its fourth quarter ending Dec. 31, the company had 8.51 million net new subscribers. It ended the period with a total of 203.7 million paid subscriptions, representing a year-over-year increase of 21.9%. Netflix thinks it will add 6 million new subscribers in the first quarter of 2021.</p><p>And the streaming services industry as a whole has a long runway for growth. According to Grand View Research, this market was worth 50.1 billion in 2020, and it is projected to expand at a compound annual growth rate (CAGR) of 21% between 2021 and 2028.</p><p>As one of the most recognizable names in this segment, Netflix is well-positioned to profit, especially since competing streaming platforms are more than capable of coexisting. One of the most powerful weapons in these platforms' arsenals is original content, and Netflix has been pouring money into original series and movies in the hopes of building a library people will want to keep coming back to.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F617555%2Fgettyimages-1174414330.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images.</p><p>These investments have played an important role in the company's success in recent years. Since the content on Netflix is different from that of some of its peers,&nbsp;many customers are more than happy to pay for subscriptions to several companies in this space. The long-term plan for Netflix is simple: Replace regular TV.</p><p>The company offers several advantages over cable: no ads, no long-term contracts, and on-demand movies and series streaming on any device. And while some cable providers have started to adapt to the new paradigm, Netflix is well on its way to continue its long winning streak in the streaming industry. Those factors make the company's stock worth a buy.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nForget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-16 23:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/><strong>Prosper Junior Bakiny</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BPOPM":"Popular","BPOPN":"Popular"},"source_url":"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2119619927","content_text":"The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the list of the 100 most popular stocks on the platform. However, some of the stocks on that list are head-scratchers. For instance, GameStop (NYSE:GME) and AMC Entertainment (NYSE:AMC) are among the top 20 most commonly held stocks on the app as of this writing.Both of these businesses are struggling, in part due to their reliance on brick-and-mortar operations, which were severely impacted by the pandemic. Further, both AMC and Gamestop were at the center of the now (in)famous short-squeeze fiasco orchestrated by traders from Reddit's r/WallStreetBets. Investors would be better off staying away from these two unpredictable companies and instead purchasing shares of Robinhood stocks with solid futures ahead of them. Two such companies worth considering are Pfizer (NYSE:PFE) and Netflix (NASDAQ:NFLX).^SPX data by YCharts1. PfizerYou've probably heard a lot about Pfizer in the past few months. The company and its partner, BioNTech, developed BNT162b2, and received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) in December, becoming the first authorized COVID-19 vaccine in the U.S. BNT162b2 has also been approved in the European Union.While Pfizer and BioNTech have to share the vaccine supply gameboard with several other companies, including Johnson & Johnson, AstraZeneca, and Moderna, the market (i.e., the entire world) is large enough for there to be multiple winners. In other words, BNT162b2 will contribute meaningfully to Pfizer's top line, especially since there is evidence of it being effective against some of the newer variants of the virus.But the company's lineup is much bigger than just this one vaccine. Some of Pfizer's top-performing products include anticoagulant Eliquis and cancer treatments Ibrance and Xtandi. Sales of Eliquis for fiscal year 2020 (ended Dec. 31) were $4.9 billion, a 17% year-over-year increase. Ibrance's revenue jumped by 9% year over year to $5.4 billion, while Xtandi's sales came in at roughly $1 billion, representing 22% growth from fiscal year 2019.Pfizer also boasts 95 programs in its pipeline, including 24 ongoing phase 3 studies. Pfizer is well-positioned to keep adding new revenue sources to its lineup every year. Lastly, it is worth noting that Pfizer spun-off its off-patent medicine unit Upjohn to the company formerly known as Mylan. The combined entity of Mylan and Upjohn is called Viatris, and it started trading on the market on Nov. 17.Pfizer decided to make this move because Upjohn's declining sales were hurting its bottom line. The company can now focus on its more profitable biopharma business. This focus should help Pfizer improve its financial results, which will help its stock recover from its underperformance relative to the market in the past year.With a more focused business, a short-term catalyst in the form of its coronavirus vaccine, other medicines with growing sales, and a rich pipeline to keep revenue sources coming, this pharma stock looks like a much better long-term bet than AMC or GameStop.Image source: Getty Images2. NetflixNetflix is already one of the leading streaming video platforms in the world, but the company isn't done growing. What are the opportunities ahead for the tech giant? First, the company is looking to add even more users to its platform. As of its fourth quarter ending Dec. 31, the company had 8.51 million net new subscribers. It ended the period with a total of 203.7 million paid subscriptions, representing a year-over-year increase of 21.9%. Netflix thinks it will add 6 million new subscribers in the first quarter of 2021.And the streaming services industry as a whole has a long runway for growth. According to Grand View Research, this market was worth 50.1 billion in 2020, and it is projected to expand at a compound annual growth rate (CAGR) of 21% between 2021 and 2028.As one of the most recognizable names in this segment, Netflix is well-positioned to profit, especially since competing streaming platforms are more than capable of coexisting. One of the most powerful weapons in these platforms' arsenals is original content, and Netflix has been pouring money into original series and movies in the hopes of building a library people will want to keep coming back to.Image source: Getty Images.These investments have played an important role in the company's success in recent years. Since the content on Netflix is different from that of some of its peers, many customers are more than happy to pay for subscriptions to several companies in this space. The long-term plan for Netflix is simple: Replace regular TV.The company offers several advantages over cable: no ads, no long-term contracts, and on-demand movies and series streaming on any device. And while some cable providers have started to adapt to the new paradigm, Netflix is well on its way to continue its long winning streak in the streaming industry. Those factors make the company's stock worth a buy.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":325760397,"gmtCreate":1615938076719,"gmtModify":1703495175077,"author":{"id":"3573227795342863","authorId":"3573227795342863","name":"TeeNyKoH","avatar":"https://static.tigerbbs.com/4bdaa509575379c4224d28e97e3cdf9e","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"n","listText":"n","text":"n","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/325760397","repostId":2119619927,"repostType":4,"repost":{"id":"2119619927","pubTimestamp":1615907700,"share":"https://www.laohu8.com/m/news/2119619927?lang=&edition=full","pubTime":"2021-03-16 23:15","market":"us","language":"en","title":"Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys","url":"https://stock-news.laohu8.com/highlight/detail?id=2119619927","media":"Prosper Junior Bakiny","summary":"No need to invest in faltering businesses -- these two winning companies are better bets.","content":"<p>The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the list of the 100 most popular stocks on the platform. However, some of the stocks on that list are head-scratchers. For instance, <b>GameStop</b> (NYSE:GME) and <b>AMC Entertainment</b> (NYSE:AMC) are among the top 20 most commonly held stocks on the app as of this writing.</p><p>Both of these businesses are struggling, in part due to their reliance on brick-and-mortar operations, which were severely impacted by the pandemic. Further, both AMC and Gamestop were at the center of the now (in)famous short-squeeze fiasco orchestrated by traders from Reddit's r/WallStreetBets. Investors would be better off staying away from these two unpredictable companies and instead purchasing shares of Robinhood stocks with solid futures ahead of them. Two such companies worth considering are <b>Pfizer</b> (NYSE:PFE) and <b>Netflix</b> (NASDAQ:NFLX).</p><p><img src=\"https://media.ycharts.com/charts/693c6b3570e5dc157db6f1cb5d80481e.png\" tg-width=\"720\" tg-height=\"387\" referrerpolicy=\"no-referrer\"></p><p>^SPX data by YCharts</p><p><b>1. Pfizer</b></p><p>You've probably heard a lot about Pfizer in the past few months. The company and its partner, <b>BioNTech</b>, developed BNT162b2, and received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) in December, becoming the first authorized COVID-19 vaccine in the U.S. BNT162b2 has also been approved in the European Union.</p><p>While Pfizer and BioNTech have to share the vaccine supply gameboard with several other companies, including <b>Johnson &amp; Johnson</b>, <b>AstraZeneca</b>, and <b>Moderna</b>, the market (i.e., the entire world) is large enough for there to be multiple winners. In other words, BNT162b2 will contribute meaningfully to Pfizer's top line, especially since there is evidence of it being effective against some of the newer variants of the virus.</p><p>But the company's lineup is much bigger than just this <a href=\"https://laohu8.com/S/AONE\">one</a> vaccine. Some of Pfizer's top-performing products include anticoagulant Eliquis and cancer treatments Ibrance and Xtandi. Sales of Eliquis for fiscal year 2020 (ended Dec. 31) were $4.9 billion, a 17% year-over-year increase. Ibrance's revenue jumped by 9% year over year to $5.4 billion, while Xtandi's sales came in at roughly $1 billion, representing 22% growth from fiscal year 2019.</p><p>Pfizer also boasts 95 programs in its pipeline, including 24 ongoing phase 3 studies. Pfizer is well-positioned to keep adding new revenue sources to its lineup every year. Lastly, it is worth noting that Pfizer spun-off its off-patent medicine unit Upjohn to the company formerly known as Mylan. The combined entity of Mylan and Upjohn is called <b>Viatris</b>, and it started trading on the market on Nov. 17.</p><p>Pfizer decided to make this move because Upjohn's declining sales were hurting its bottom line. The company can now focus on its more profitable biopharma business. This focus should help Pfizer improve its financial results, which will help its stock recover from its underperformance relative to the market in the past year.</p><p>With a more focused business, a short-term catalyst in the form of its coronavirus vaccine, other medicines with growing sales, and a rich pipeline to keep revenue sources coming, this pharma stock looks like a much better long-term bet than AMC or GameStop.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F617555%2Fgettyimages-1291715271.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images</p><p><b>2. Netflix</b></p><p>Netflix is already <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leading streaming video platforms in the world, but the company isn't done growing. What are the opportunities ahead for the tech giant? First, the company is looking to add even more users to its platform. As of its fourth quarter ending Dec. 31, the company had 8.51 million net new subscribers. It ended the period with a total of 203.7 million paid subscriptions, representing a year-over-year increase of 21.9%. Netflix thinks it will add 6 million new subscribers in the first quarter of 2021.</p><p>And the streaming services industry as a whole has a long runway for growth. According to Grand View Research, this market was worth 50.1 billion in 2020, and it is projected to expand at a compound annual growth rate (CAGR) of 21% between 2021 and 2028.</p><p>As one of the most recognizable names in this segment, Netflix is well-positioned to profit, especially since competing streaming platforms are more than capable of coexisting. One of the most powerful weapons in these platforms' arsenals is original content, and Netflix has been pouring money into original series and movies in the hopes of building a library people will want to keep coming back to.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F617555%2Fgettyimages-1174414330.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images.</p><p>These investments have played an important role in the company's success in recent years. Since the content on Netflix is different from that of some of its peers,&nbsp;many customers are more than happy to pay for subscriptions to several companies in this space. The long-term plan for Netflix is simple: Replace regular TV.</p><p>The company offers several advantages over cable: no ads, no long-term contracts, and on-demand movies and series streaming on any device. And while some cable providers have started to adapt to the new paradigm, Netflix is well on its way to continue its long winning streak in the streaming industry. Those factors make the company's stock worth a buy.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nForget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-16 23:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/><strong>Prosper Junior Bakiny</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BPOPM":"Popular","BPOPN":"Popular"},"source_url":"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2119619927","content_text":"The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the list of the 100 most popular stocks on the platform. However, some of the stocks on that list are head-scratchers. For instance, GameStop (NYSE:GME) and AMC Entertainment (NYSE:AMC) are among the top 20 most commonly held stocks on the app as of this writing.Both of these businesses are struggling, in part due to their reliance on brick-and-mortar operations, which were severely impacted by the pandemic. Further, both AMC and Gamestop were at the center of the now (in)famous short-squeeze fiasco orchestrated by traders from Reddit's r/WallStreetBets. Investors would be better off staying away from these two unpredictable companies and instead purchasing shares of Robinhood stocks with solid futures ahead of them. Two such companies worth considering are Pfizer (NYSE:PFE) and Netflix (NASDAQ:NFLX).^SPX data by YCharts1. PfizerYou've probably heard a lot about Pfizer in the past few months. The company and its partner, BioNTech, developed BNT162b2, and received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) in December, becoming the first authorized COVID-19 vaccine in the U.S. BNT162b2 has also been approved in the European Union.While Pfizer and BioNTech have to share the vaccine supply gameboard with several other companies, including Johnson & Johnson, AstraZeneca, and Moderna, the market (i.e., the entire world) is large enough for there to be multiple winners. In other words, BNT162b2 will contribute meaningfully to Pfizer's top line, especially since there is evidence of it being effective against some of the newer variants of the virus.But the company's lineup is much bigger than just this one vaccine. Some of Pfizer's top-performing products include anticoagulant Eliquis and cancer treatments Ibrance and Xtandi. Sales of Eliquis for fiscal year 2020 (ended Dec. 31) were $4.9 billion, a 17% year-over-year increase. Ibrance's revenue jumped by 9% year over year to $5.4 billion, while Xtandi's sales came in at roughly $1 billion, representing 22% growth from fiscal year 2019.Pfizer also boasts 95 programs in its pipeline, including 24 ongoing phase 3 studies. Pfizer is well-positioned to keep adding new revenue sources to its lineup every year. Lastly, it is worth noting that Pfizer spun-off its off-patent medicine unit Upjohn to the company formerly known as Mylan. The combined entity of Mylan and Upjohn is called Viatris, and it started trading on the market on Nov. 17.Pfizer decided to make this move because Upjohn's declining sales were hurting its bottom line. The company can now focus on its more profitable biopharma business. This focus should help Pfizer improve its financial results, which will help its stock recover from its underperformance relative to the market in the past year.With a more focused business, a short-term catalyst in the form of its coronavirus vaccine, other medicines with growing sales, and a rich pipeline to keep revenue sources coming, this pharma stock looks like a much better long-term bet than AMC or GameStop.Image source: Getty Images2. NetflixNetflix is already one of the leading streaming video platforms in the world, but the company isn't done growing. What are the opportunities ahead for the tech giant? First, the company is looking to add even more users to its platform. As of its fourth quarter ending Dec. 31, the company had 8.51 million net new subscribers. It ended the period with a total of 203.7 million paid subscriptions, representing a year-over-year increase of 21.9%. Netflix thinks it will add 6 million new subscribers in the first quarter of 2021.And the streaming services industry as a whole has a long runway for growth. According to Grand View Research, this market was worth 50.1 billion in 2020, and it is projected to expand at a compound annual growth rate (CAGR) of 21% between 2021 and 2028.As one of the most recognizable names in this segment, Netflix is well-positioned to profit, especially since competing streaming platforms are more than capable of coexisting. One of the most powerful weapons in these platforms' arsenals is original content, and Netflix has been pouring money into original series and movies in the hopes of building a library people will want to keep coming back to.Image source: Getty Images.These investments have played an important role in the company's success in recent years. Since the content on Netflix is different from that of some of its peers, many customers are more than happy to pay for subscriptions to several companies in this space. The long-term plan for Netflix is simple: Replace regular TV.The company offers several advantages over cable: no ads, no long-term contracts, and on-demand movies and series streaming on any device. And while some cable providers have started to adapt to the new paradigm, Netflix is well on its way to continue its long winning streak in the streaming industry. Those factors make the company's stock worth a buy.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":325788604,"gmtCreate":1615937593908,"gmtModify":1703495167069,"author":{"id":"3567237066621649","authorId":"3567237066621649","name":"小刀锯大树还不算事","avatar":"https://static.tigerbbs.com/940f8c70e8832a3b7e32d4387fcfce4c","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Popular is the keyword.","listText":"Popular is the keyword.","text":"Popular is the keyword.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/325788604","repostId":2119619927,"repostType":4,"repost":{"id":"2119619927","pubTimestamp":1615907700,"share":"https://www.laohu8.com/m/news/2119619927?lang=&edition=full","pubTime":"2021-03-16 23:15","market":"us","language":"en","title":"Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys","url":"https://stock-news.laohu8.com/highlight/detail?id=2119619927","media":"Prosper Junior Bakiny","summary":"No need to invest in faltering businesses -- these two winning companies are better bets.","content":"<p>The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the list of the 100 most popular stocks on the platform. However, some of the stocks on that list are head-scratchers. For instance, <b>GameStop</b> (NYSE:GME) and <b>AMC Entertainment</b> (NYSE:AMC) are among the top 20 most commonly held stocks on the app as of this writing.</p><p>Both of these businesses are struggling, in part due to their reliance on brick-and-mortar operations, which were severely impacted by the pandemic. Further, both AMC and Gamestop were at the center of the now (in)famous short-squeeze fiasco orchestrated by traders from Reddit's r/WallStreetBets. Investors would be better off staying away from these two unpredictable companies and instead purchasing shares of Robinhood stocks with solid futures ahead of them. Two such companies worth considering are <b>Pfizer</b> (NYSE:PFE) and <b>Netflix</b> (NASDAQ:NFLX).</p><p><img src=\"https://media.ycharts.com/charts/693c6b3570e5dc157db6f1cb5d80481e.png\" tg-width=\"720\" tg-height=\"387\" referrerpolicy=\"no-referrer\"></p><p>^SPX data by YCharts</p><p><b>1. Pfizer</b></p><p>You've probably heard a lot about Pfizer in the past few months. The company and its partner, <b>BioNTech</b>, developed BNT162b2, and received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) in December, becoming the first authorized COVID-19 vaccine in the U.S. BNT162b2 has also been approved in the European Union.</p><p>While Pfizer and BioNTech have to share the vaccine supply gameboard with several other companies, including <b>Johnson &amp; Johnson</b>, <b>AstraZeneca</b>, and <b>Moderna</b>, the market (i.e., the entire world) is large enough for there to be multiple winners. In other words, BNT162b2 will contribute meaningfully to Pfizer's top line, especially since there is evidence of it being effective against some of the newer variants of the virus.</p><p>But the company's lineup is much bigger than just this <a href=\"https://laohu8.com/S/AONE\">one</a> vaccine. Some of Pfizer's top-performing products include anticoagulant Eliquis and cancer treatments Ibrance and Xtandi. Sales of Eliquis for fiscal year 2020 (ended Dec. 31) were $4.9 billion, a 17% year-over-year increase. Ibrance's revenue jumped by 9% year over year to $5.4 billion, while Xtandi's sales came in at roughly $1 billion, representing 22% growth from fiscal year 2019.</p><p>Pfizer also boasts 95 programs in its pipeline, including 24 ongoing phase 3 studies. Pfizer is well-positioned to keep adding new revenue sources to its lineup every year. Lastly, it is worth noting that Pfizer spun-off its off-patent medicine unit Upjohn to the company formerly known as Mylan. The combined entity of Mylan and Upjohn is called <b>Viatris</b>, and it started trading on the market on Nov. 17.</p><p>Pfizer decided to make this move because Upjohn's declining sales were hurting its bottom line. The company can now focus on its more profitable biopharma business. This focus should help Pfizer improve its financial results, which will help its stock recover from its underperformance relative to the market in the past year.</p><p>With a more focused business, a short-term catalyst in the form of its coronavirus vaccine, other medicines with growing sales, and a rich pipeline to keep revenue sources coming, this pharma stock looks like a much better long-term bet than AMC or GameStop.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F617555%2Fgettyimages-1291715271.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images</p><p><b>2. Netflix</b></p><p>Netflix is already <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leading streaming video platforms in the world, but the company isn't done growing. What are the opportunities ahead for the tech giant? First, the company is looking to add even more users to its platform. As of its fourth quarter ending Dec. 31, the company had 8.51 million net new subscribers. It ended the period with a total of 203.7 million paid subscriptions, representing a year-over-year increase of 21.9%. Netflix thinks it will add 6 million new subscribers in the first quarter of 2021.</p><p>And the streaming services industry as a whole has a long runway for growth. According to Grand View Research, this market was worth 50.1 billion in 2020, and it is projected to expand at a compound annual growth rate (CAGR) of 21% between 2021 and 2028.</p><p>As one of the most recognizable names in this segment, Netflix is well-positioned to profit, especially since competing streaming platforms are more than capable of coexisting. One of the most powerful weapons in these platforms' arsenals is original content, and Netflix has been pouring money into original series and movies in the hopes of building a library people will want to keep coming back to.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F617555%2Fgettyimages-1174414330.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images.</p><p>These investments have played an important role in the company's success in recent years. Since the content on Netflix is different from that of some of its peers,&nbsp;many customers are more than happy to pay for subscriptions to several companies in this space. The long-term plan for Netflix is simple: Replace regular TV.</p><p>The company offers several advantages over cable: no ads, no long-term contracts, and on-demand movies and series streaming on any device. And while some cable providers have started to adapt to the new paradigm, Netflix is well on its way to continue its long winning streak in the streaming industry. Those factors make the company's stock worth a buy.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nForget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-16 23:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/><strong>Prosper Junior Bakiny</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BPOPM":"Popular","BPOPN":"Popular"},"source_url":"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2119619927","content_text":"The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the list of the 100 most popular stocks on the platform. However, some of the stocks on that list are head-scratchers. For instance, GameStop (NYSE:GME) and AMC Entertainment (NYSE:AMC) are among the top 20 most commonly held stocks on the app as of this writing.Both of these businesses are struggling, in part due to their reliance on brick-and-mortar operations, which were severely impacted by the pandemic. Further, both AMC and Gamestop were at the center of the now (in)famous short-squeeze fiasco orchestrated by traders from Reddit's r/WallStreetBets. Investors would be better off staying away from these two unpredictable companies and instead purchasing shares of Robinhood stocks with solid futures ahead of them. Two such companies worth considering are Pfizer (NYSE:PFE) and Netflix (NASDAQ:NFLX).^SPX data by YCharts1. PfizerYou've probably heard a lot about Pfizer in the past few months. The company and its partner, BioNTech, developed BNT162b2, and received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) in December, becoming the first authorized COVID-19 vaccine in the U.S. BNT162b2 has also been approved in the European Union.While Pfizer and BioNTech have to share the vaccine supply gameboard with several other companies, including Johnson & Johnson, AstraZeneca, and Moderna, the market (i.e., the entire world) is large enough for there to be multiple winners. In other words, BNT162b2 will contribute meaningfully to Pfizer's top line, especially since there is evidence of it being effective against some of the newer variants of the virus.But the company's lineup is much bigger than just this one vaccine. Some of Pfizer's top-performing products include anticoagulant Eliquis and cancer treatments Ibrance and Xtandi. Sales of Eliquis for fiscal year 2020 (ended Dec. 31) were $4.9 billion, a 17% year-over-year increase. Ibrance's revenue jumped by 9% year over year to $5.4 billion, while Xtandi's sales came in at roughly $1 billion, representing 22% growth from fiscal year 2019.Pfizer also boasts 95 programs in its pipeline, including 24 ongoing phase 3 studies. Pfizer is well-positioned to keep adding new revenue sources to its lineup every year. Lastly, it is worth noting that Pfizer spun-off its off-patent medicine unit Upjohn to the company formerly known as Mylan. The combined entity of Mylan and Upjohn is called Viatris, and it started trading on the market on Nov. 17.Pfizer decided to make this move because Upjohn's declining sales were hurting its bottom line. The company can now focus on its more profitable biopharma business. This focus should help Pfizer improve its financial results, which will help its stock recover from its underperformance relative to the market in the past year.With a more focused business, a short-term catalyst in the form of its coronavirus vaccine, other medicines with growing sales, and a rich pipeline to keep revenue sources coming, this pharma stock looks like a much better long-term bet than AMC or GameStop.Image source: Getty Images2. NetflixNetflix is already one of the leading streaming video platforms in the world, but the company isn't done growing. What are the opportunities ahead for the tech giant? First, the company is looking to add even more users to its platform. As of its fourth quarter ending Dec. 31, the company had 8.51 million net new subscribers. It ended the period with a total of 203.7 million paid subscriptions, representing a year-over-year increase of 21.9%. Netflix thinks it will add 6 million new subscribers in the first quarter of 2021.And the streaming services industry as a whole has a long runway for growth. According to Grand View Research, this market was worth 50.1 billion in 2020, and it is projected to expand at a compound annual growth rate (CAGR) of 21% between 2021 and 2028.As one of the most recognizable names in this segment, Netflix is well-positioned to profit, especially since competing streaming platforms are more than capable of coexisting. One of the most powerful weapons in these platforms' arsenals is original content, and Netflix has been pouring money into original series and movies in the hopes of building a library people will want to keep coming back to.Image source: Getty Images.These investments have played an important role in the company's success in recent years. Since the content on Netflix is different from that of some of its peers, many customers are more than happy to pay for subscriptions to several companies in this space. The long-term plan for Netflix is simple: Replace regular TV.The company offers several advantages over cable: no ads, no long-term contracts, and on-demand movies and series streaming on any device. And while some cable providers have started to adapt to the new paradigm, Netflix is well on its way to continue its long winning streak in the streaming industry. Those factors make the company's stock worth a buy.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":325783675,"gmtCreate":1615937414097,"gmtModify":1703495164629,"author":{"id":"3563253186452228","authorId":"3563253186452228","name":"Sheryl85","avatar":"https://static.tigerbbs.com/b7a9183a9332355f694e2f0af874b0ed","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"ok noted","listText":"ok noted","text":"ok noted","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/325783675","repostId":2119619927,"repostType":4,"repost":{"id":"2119619927","pubTimestamp":1615907700,"share":"https://www.laohu8.com/m/news/2119619927?lang=&edition=full","pubTime":"2021-03-16 23:15","market":"us","language":"en","title":"Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys","url":"https://stock-news.laohu8.com/highlight/detail?id=2119619927","media":"Prosper Junior Bakiny","summary":"No need to invest in faltering businesses -- these two winning companies are better bets.","content":"<p>The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the list of the 100 most popular stocks on the platform. However, some of the stocks on that list are head-scratchers. For instance, <b>GameStop</b> (NYSE:GME) and <b>AMC Entertainment</b> (NYSE:AMC) are among the top 20 most commonly held stocks on the app as of this writing.</p><p>Both of these businesses are struggling, in part due to their reliance on brick-and-mortar operations, which were severely impacted by the pandemic. Further, both AMC and Gamestop were at the center of the now (in)famous short-squeeze fiasco orchestrated by traders from Reddit's r/WallStreetBets. Investors would be better off staying away from these two unpredictable companies and instead purchasing shares of Robinhood stocks with solid futures ahead of them. Two such companies worth considering are <b>Pfizer</b> (NYSE:PFE) and <b>Netflix</b> (NASDAQ:NFLX).</p><p><img src=\"https://media.ycharts.com/charts/693c6b3570e5dc157db6f1cb5d80481e.png\" tg-width=\"720\" tg-height=\"387\" referrerpolicy=\"no-referrer\"></p><p>^SPX data by YCharts</p><p><b>1. Pfizer</b></p><p>You've probably heard a lot about Pfizer in the past few months. The company and its partner, <b>BioNTech</b>, developed BNT162b2, and received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) in December, becoming the first authorized COVID-19 vaccine in the U.S. BNT162b2 has also been approved in the European Union.</p><p>While Pfizer and BioNTech have to share the vaccine supply gameboard with several other companies, including <b>Johnson &amp; Johnson</b>, <b>AstraZeneca</b>, and <b>Moderna</b>, the market (i.e., the entire world) is large enough for there to be multiple winners. In other words, BNT162b2 will contribute meaningfully to Pfizer's top line, especially since there is evidence of it being effective against some of the newer variants of the virus.</p><p>But the company's lineup is much bigger than just this <a href=\"https://laohu8.com/S/AONE\">one</a> vaccine. Some of Pfizer's top-performing products include anticoagulant Eliquis and cancer treatments Ibrance and Xtandi. Sales of Eliquis for fiscal year 2020 (ended Dec. 31) were $4.9 billion, a 17% year-over-year increase. Ibrance's revenue jumped by 9% year over year to $5.4 billion, while Xtandi's sales came in at roughly $1 billion, representing 22% growth from fiscal year 2019.</p><p>Pfizer also boasts 95 programs in its pipeline, including 24 ongoing phase 3 studies. Pfizer is well-positioned to keep adding new revenue sources to its lineup every year. Lastly, it is worth noting that Pfizer spun-off its off-patent medicine unit Upjohn to the company formerly known as Mylan. The combined entity of Mylan and Upjohn is called <b>Viatris</b>, and it started trading on the market on Nov. 17.</p><p>Pfizer decided to make this move because Upjohn's declining sales were hurting its bottom line. The company can now focus on its more profitable biopharma business. This focus should help Pfizer improve its financial results, which will help its stock recover from its underperformance relative to the market in the past year.</p><p>With a more focused business, a short-term catalyst in the form of its coronavirus vaccine, other medicines with growing sales, and a rich pipeline to keep revenue sources coming, this pharma stock looks like a much better long-term bet than AMC or GameStop.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F617555%2Fgettyimages-1291715271.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images</p><p><b>2. Netflix</b></p><p>Netflix is already <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leading streaming video platforms in the world, but the company isn't done growing. What are the opportunities ahead for the tech giant? First, the company is looking to add even more users to its platform. As of its fourth quarter ending Dec. 31, the company had 8.51 million net new subscribers. It ended the period with a total of 203.7 million paid subscriptions, representing a year-over-year increase of 21.9%. Netflix thinks it will add 6 million new subscribers in the first quarter of 2021.</p><p>And the streaming services industry as a whole has a long runway for growth. According to Grand View Research, this market was worth 50.1 billion in 2020, and it is projected to expand at a compound annual growth rate (CAGR) of 21% between 2021 and 2028.</p><p>As one of the most recognizable names in this segment, Netflix is well-positioned to profit, especially since competing streaming platforms are more than capable of coexisting. One of the most powerful weapons in these platforms' arsenals is original content, and Netflix has been pouring money into original series and movies in the hopes of building a library people will want to keep coming back to.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F617555%2Fgettyimages-1174414330.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images.</p><p>These investments have played an important role in the company's success in recent years. Since the content on Netflix is different from that of some of its peers,&nbsp;many customers are more than happy to pay for subscriptions to several companies in this space. The long-term plan for Netflix is simple: Replace regular TV.</p><p>The company offers several advantages over cable: no ads, no long-term contracts, and on-demand movies and series streaming on any device. And while some cable providers have started to adapt to the new paradigm, Netflix is well on its way to continue its long winning streak in the streaming industry. Those factors make the company's stock worth a buy.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nForget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-16 23:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/><strong>Prosper Junior Bakiny</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BPOPM":"Popular","BPOPN":"Popular"},"source_url":"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2119619927","content_text":"The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the list of the 100 most popular stocks on the platform. However, some of the stocks on that list are head-scratchers. For instance, GameStop (NYSE:GME) and AMC Entertainment (NYSE:AMC) are among the top 20 most commonly held stocks on the app as of this writing.Both of these businesses are struggling, in part due to their reliance on brick-and-mortar operations, which were severely impacted by the pandemic. Further, both AMC and Gamestop were at the center of the now (in)famous short-squeeze fiasco orchestrated by traders from Reddit's r/WallStreetBets. Investors would be better off staying away from these two unpredictable companies and instead purchasing shares of Robinhood stocks with solid futures ahead of them. Two such companies worth considering are Pfizer (NYSE:PFE) and Netflix (NASDAQ:NFLX).^SPX data by YCharts1. PfizerYou've probably heard a lot about Pfizer in the past few months. The company and its partner, BioNTech, developed BNT162b2, and received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) in December, becoming the first authorized COVID-19 vaccine in the U.S. BNT162b2 has also been approved in the European Union.While Pfizer and BioNTech have to share the vaccine supply gameboard with several other companies, including Johnson & Johnson, AstraZeneca, and Moderna, the market (i.e., the entire world) is large enough for there to be multiple winners. In other words, BNT162b2 will contribute meaningfully to Pfizer's top line, especially since there is evidence of it being effective against some of the newer variants of the virus.But the company's lineup is much bigger than just this one vaccine. Some of Pfizer's top-performing products include anticoagulant Eliquis and cancer treatments Ibrance and Xtandi. Sales of Eliquis for fiscal year 2020 (ended Dec. 31) were $4.9 billion, a 17% year-over-year increase. Ibrance's revenue jumped by 9% year over year to $5.4 billion, while Xtandi's sales came in at roughly $1 billion, representing 22% growth from fiscal year 2019.Pfizer also boasts 95 programs in its pipeline, including 24 ongoing phase 3 studies. Pfizer is well-positioned to keep adding new revenue sources to its lineup every year. Lastly, it is worth noting that Pfizer spun-off its off-patent medicine unit Upjohn to the company formerly known as Mylan. The combined entity of Mylan and Upjohn is called Viatris, and it started trading on the market on Nov. 17.Pfizer decided to make this move because Upjohn's declining sales were hurting its bottom line. The company can now focus on its more profitable biopharma business. This focus should help Pfizer improve its financial results, which will help its stock recover from its underperformance relative to the market in the past year.With a more focused business, a short-term catalyst in the form of its coronavirus vaccine, other medicines with growing sales, and a rich pipeline to keep revenue sources coming, this pharma stock looks like a much better long-term bet than AMC or GameStop.Image source: Getty Images2. NetflixNetflix is already one of the leading streaming video platforms in the world, but the company isn't done growing. What are the opportunities ahead for the tech giant? First, the company is looking to add even more users to its platform. As of its fourth quarter ending Dec. 31, the company had 8.51 million net new subscribers. It ended the period with a total of 203.7 million paid subscriptions, representing a year-over-year increase of 21.9%. Netflix thinks it will add 6 million new subscribers in the first quarter of 2021.And the streaming services industry as a whole has a long runway for growth. According to Grand View Research, this market was worth 50.1 billion in 2020, and it is projected to expand at a compound annual growth rate (CAGR) of 21% between 2021 and 2028.As one of the most recognizable names in this segment, Netflix is well-positioned to profit, especially since competing streaming platforms are more than capable of coexisting. One of the most powerful weapons in these platforms' arsenals is original content, and Netflix has been pouring money into original series and movies in the hopes of building a library people will want to keep coming back to.Image source: Getty Images.These investments have played an important role in the company's success in recent years. Since the content on Netflix is different from that of some of its peers, many customers are more than happy to pay for subscriptions to several companies in this space. The long-term plan for Netflix is simple: Replace regular TV.The company offers several advantages over cable: no ads, no long-term contracts, and on-demand movies and series streaming on any device. And while some cable providers have started to adapt to the new paradigm, Netflix is well on its way to continue its long winning streak in the streaming industry. Those factors make the company's stock worth a buy.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":325789640,"gmtCreate":1615937343980,"gmtModify":1703495163755,"author":{"id":"3576880831453882","authorId":"3576880831453882","name":"capsulefong","avatar":"https://static.tigerbbs.com/25f18e70d07b538bd6b81cf112a09cde","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/325789640","repostId":2119619927,"repostType":4,"repost":{"id":"2119619927","pubTimestamp":1615907700,"share":"https://www.laohu8.com/m/news/2119619927?lang=&edition=full","pubTime":"2021-03-16 23:15","market":"us","language":"en","title":"Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys","url":"https://stock-news.laohu8.com/highlight/detail?id=2119619927","media":"Prosper Junior Bakiny","summary":"No need to invest in faltering businesses -- these two winning companies are better bets.","content":"<p>The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the list of the 100 most popular stocks on the platform. However, some of the stocks on that list are head-scratchers. For instance, <b>GameStop</b> (NYSE:GME) and <b>AMC Entertainment</b> (NYSE:AMC) are among the top 20 most commonly held stocks on the app as of this writing.</p><p>Both of these businesses are struggling, in part due to their reliance on brick-and-mortar operations, which were severely impacted by the pandemic. Further, both AMC and Gamestop were at the center of the now (in)famous short-squeeze fiasco orchestrated by traders from Reddit's r/WallStreetBets. Investors would be better off staying away from these two unpredictable companies and instead purchasing shares of Robinhood stocks with solid futures ahead of them. Two such companies worth considering are <b>Pfizer</b> (NYSE:PFE) and <b>Netflix</b> (NASDAQ:NFLX).</p><p><img src=\"https://media.ycharts.com/charts/693c6b3570e5dc157db6f1cb5d80481e.png\" tg-width=\"720\" tg-height=\"387\" referrerpolicy=\"no-referrer\"></p><p>^SPX data by YCharts</p><p><b>1. Pfizer</b></p><p>You've probably heard a lot about Pfizer in the past few months. The company and its partner, <b>BioNTech</b>, developed BNT162b2, and received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) in December, becoming the first authorized COVID-19 vaccine in the U.S. BNT162b2 has also been approved in the European Union.</p><p>While Pfizer and BioNTech have to share the vaccine supply gameboard with several other companies, including <b>Johnson &amp; Johnson</b>, <b>AstraZeneca</b>, and <b>Moderna</b>, the market (i.e., the entire world) is large enough for there to be multiple winners. In other words, BNT162b2 will contribute meaningfully to Pfizer's top line, especially since there is evidence of it being effective against some of the newer variants of the virus.</p><p>But the company's lineup is much bigger than just this <a href=\"https://laohu8.com/S/AONE\">one</a> vaccine. Some of Pfizer's top-performing products include anticoagulant Eliquis and cancer treatments Ibrance and Xtandi. Sales of Eliquis for fiscal year 2020 (ended Dec. 31) were $4.9 billion, a 17% year-over-year increase. Ibrance's revenue jumped by 9% year over year to $5.4 billion, while Xtandi's sales came in at roughly $1 billion, representing 22% growth from fiscal year 2019.</p><p>Pfizer also boasts 95 programs in its pipeline, including 24 ongoing phase 3 studies. Pfizer is well-positioned to keep adding new revenue sources to its lineup every year. Lastly, it is worth noting that Pfizer spun-off its off-patent medicine unit Upjohn to the company formerly known as Mylan. The combined entity of Mylan and Upjohn is called <b>Viatris</b>, and it started trading on the market on Nov. 17.</p><p>Pfizer decided to make this move because Upjohn's declining sales were hurting its bottom line. The company can now focus on its more profitable biopharma business. This focus should help Pfizer improve its financial results, which will help its stock recover from its underperformance relative to the market in the past year.</p><p>With a more focused business, a short-term catalyst in the form of its coronavirus vaccine, other medicines with growing sales, and a rich pipeline to keep revenue sources coming, this pharma stock looks like a much better long-term bet than AMC or GameStop.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F617555%2Fgettyimages-1291715271.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images</p><p><b>2. Netflix</b></p><p>Netflix is already <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leading streaming video platforms in the world, but the company isn't done growing. What are the opportunities ahead for the tech giant? First, the company is looking to add even more users to its platform. As of its fourth quarter ending Dec. 31, the company had 8.51 million net new subscribers. It ended the period with a total of 203.7 million paid subscriptions, representing a year-over-year increase of 21.9%. Netflix thinks it will add 6 million new subscribers in the first quarter of 2021.</p><p>And the streaming services industry as a whole has a long runway for growth. According to Grand View Research, this market was worth 50.1 billion in 2020, and it is projected to expand at a compound annual growth rate (CAGR) of 21% between 2021 and 2028.</p><p>As one of the most recognizable names in this segment, Netflix is well-positioned to profit, especially since competing streaming platforms are more than capable of coexisting. One of the most powerful weapons in these platforms' arsenals is original content, and Netflix has been pouring money into original series and movies in the hopes of building a library people will want to keep coming back to.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F617555%2Fgettyimages-1174414330.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images.</p><p>These investments have played an important role in the company's success in recent years. Since the content on Netflix is different from that of some of its peers,&nbsp;many customers are more than happy to pay for subscriptions to several companies in this space. The long-term plan for Netflix is simple: Replace regular TV.</p><p>The company offers several advantages over cable: no ads, no long-term contracts, and on-demand movies and series streaming on any device. And while some cable providers have started to adapt to the new paradigm, Netflix is well on its way to continue its long winning streak in the streaming industry. Those factors make the company's stock worth a buy.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nForget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-16 23:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/><strong>Prosper Junior Bakiny</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BPOPM":"Popular","BPOPN":"Popular"},"source_url":"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2119619927","content_text":"The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the list of the 100 most popular stocks on the platform. However, some of the stocks on that list are head-scratchers. For instance, GameStop (NYSE:GME) and AMC Entertainment (NYSE:AMC) are among the top 20 most commonly held stocks on the app as of this writing.Both of these businesses are struggling, in part due to their reliance on brick-and-mortar operations, which were severely impacted by the pandemic. Further, both AMC and Gamestop were at the center of the now (in)famous short-squeeze fiasco orchestrated by traders from Reddit's r/WallStreetBets. Investors would be better off staying away from these two unpredictable companies and instead purchasing shares of Robinhood stocks with solid futures ahead of them. Two such companies worth considering are Pfizer (NYSE:PFE) and Netflix (NASDAQ:NFLX).^SPX data by YCharts1. PfizerYou've probably heard a lot about Pfizer in the past few months. The company and its partner, BioNTech, developed BNT162b2, and received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) in December, becoming the first authorized COVID-19 vaccine in the U.S. BNT162b2 has also been approved in the European Union.While Pfizer and BioNTech have to share the vaccine supply gameboard with several other companies, including Johnson & Johnson, AstraZeneca, and Moderna, the market (i.e., the entire world) is large enough for there to be multiple winners. In other words, BNT162b2 will contribute meaningfully to Pfizer's top line, especially since there is evidence of it being effective against some of the newer variants of the virus.But the company's lineup is much bigger than just this one vaccine. Some of Pfizer's top-performing products include anticoagulant Eliquis and cancer treatments Ibrance and Xtandi. Sales of Eliquis for fiscal year 2020 (ended Dec. 31) were $4.9 billion, a 17% year-over-year increase. Ibrance's revenue jumped by 9% year over year to $5.4 billion, while Xtandi's sales came in at roughly $1 billion, representing 22% growth from fiscal year 2019.Pfizer also boasts 95 programs in its pipeline, including 24 ongoing phase 3 studies. Pfizer is well-positioned to keep adding new revenue sources to its lineup every year. Lastly, it is worth noting that Pfizer spun-off its off-patent medicine unit Upjohn to the company formerly known as Mylan. The combined entity of Mylan and Upjohn is called Viatris, and it started trading on the market on Nov. 17.Pfizer decided to make this move because Upjohn's declining sales were hurting its bottom line. The company can now focus on its more profitable biopharma business. This focus should help Pfizer improve its financial results, which will help its stock recover from its underperformance relative to the market in the past year.With a more focused business, a short-term catalyst in the form of its coronavirus vaccine, other medicines with growing sales, and a rich pipeline to keep revenue sources coming, this pharma stock looks like a much better long-term bet than AMC or GameStop.Image source: Getty Images2. NetflixNetflix is already one of the leading streaming video platforms in the world, but the company isn't done growing. What are the opportunities ahead for the tech giant? First, the company is looking to add even more users to its platform. As of its fourth quarter ending Dec. 31, the company had 8.51 million net new subscribers. It ended the period with a total of 203.7 million paid subscriptions, representing a year-over-year increase of 21.9%. Netflix thinks it will add 6 million new subscribers in the first quarter of 2021.And the streaming services industry as a whole has a long runway for growth. According to Grand View Research, this market was worth 50.1 billion in 2020, and it is projected to expand at a compound annual growth rate (CAGR) of 21% between 2021 and 2028.As one of the most recognizable names in this segment, Netflix is well-positioned to profit, especially since competing streaming platforms are more than capable of coexisting. One of the most powerful weapons in these platforms' arsenals is original content, and Netflix has been pouring money into original series and movies in the hopes of building a library people will want to keep coming back to.Image source: Getty Images.These investments have played an important role in the company's success in recent years. Since the content on Netflix is different from that of some of its peers, many customers are more than happy to pay for subscriptions to several companies in this space. The long-term plan for Netflix is simple: Replace regular TV.The company offers several advantages over cable: no ads, no long-term contracts, and on-demand movies and series streaming on any device. And while some cable providers have started to adapt to the new paradigm, Netflix is well on its way to continue its long winning streak in the streaming industry. Those factors make the company's stock worth a buy.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":325712374,"gmtCreate":1615936904398,"gmtModify":1703495156743,"author":{"id":"3576021125565845","authorId":"3576021125565845","name":"Kuxn","avatar":"https://static.tigerbbs.com/735264c1e1b135b6b4b9925b858173c7","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Good write up","listText":"Good write up","text":"Good write up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/325712374","repostId":2119619927,"repostType":4,"repost":{"id":"2119619927","pubTimestamp":1615907700,"share":"https://www.laohu8.com/m/news/2119619927?lang=&edition=full","pubTime":"2021-03-16 23:15","market":"us","language":"en","title":"Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys","url":"https://stock-news.laohu8.com/highlight/detail?id=2119619927","media":"Prosper Junior Bakiny","summary":"No need to invest in faltering businesses -- these two winning companies are better bets.","content":"<p>The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the list of the 100 most popular stocks on the platform. However, some of the stocks on that list are head-scratchers. For instance, <b>GameStop</b> (NYSE:GME) and <b>AMC Entertainment</b> (NYSE:AMC) are among the top 20 most commonly held stocks on the app as of this writing.</p><p>Both of these businesses are struggling, in part due to their reliance on brick-and-mortar operations, which were severely impacted by the pandemic. Further, both AMC and Gamestop were at the center of the now (in)famous short-squeeze fiasco orchestrated by traders from Reddit's r/WallStreetBets. Investors would be better off staying away from these two unpredictable companies and instead purchasing shares of Robinhood stocks with solid futures ahead of them. Two such companies worth considering are <b>Pfizer</b> (NYSE:PFE) and <b>Netflix</b> (NASDAQ:NFLX).</p><p><img src=\"https://media.ycharts.com/charts/693c6b3570e5dc157db6f1cb5d80481e.png\" tg-width=\"720\" tg-height=\"387\" referrerpolicy=\"no-referrer\"></p><p>^SPX data by YCharts</p><p><b>1. Pfizer</b></p><p>You've probably heard a lot about Pfizer in the past few months. The company and its partner, <b>BioNTech</b>, developed BNT162b2, and received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) in December, becoming the first authorized COVID-19 vaccine in the U.S. BNT162b2 has also been approved in the European Union.</p><p>While Pfizer and BioNTech have to share the vaccine supply gameboard with several other companies, including <b>Johnson &amp; Johnson</b>, <b>AstraZeneca</b>, and <b>Moderna</b>, the market (i.e., the entire world) is large enough for there to be multiple winners. In other words, BNT162b2 will contribute meaningfully to Pfizer's top line, especially since there is evidence of it being effective against some of the newer variants of the virus.</p><p>But the company's lineup is much bigger than just this <a href=\"https://laohu8.com/S/AONE\">one</a> vaccine. Some of Pfizer's top-performing products include anticoagulant Eliquis and cancer treatments Ibrance and Xtandi. Sales of Eliquis for fiscal year 2020 (ended Dec. 31) were $4.9 billion, a 17% year-over-year increase. Ibrance's revenue jumped by 9% year over year to $5.4 billion, while Xtandi's sales came in at roughly $1 billion, representing 22% growth from fiscal year 2019.</p><p>Pfizer also boasts 95 programs in its pipeline, including 24 ongoing phase 3 studies. Pfizer is well-positioned to keep adding new revenue sources to its lineup every year. Lastly, it is worth noting that Pfizer spun-off its off-patent medicine unit Upjohn to the company formerly known as Mylan. The combined entity of Mylan and Upjohn is called <b>Viatris</b>, and it started trading on the market on Nov. 17.</p><p>Pfizer decided to make this move because Upjohn's declining sales were hurting its bottom line. The company can now focus on its more profitable biopharma business. This focus should help Pfizer improve its financial results, which will help its stock recover from its underperformance relative to the market in the past year.</p><p>With a more focused business, a short-term catalyst in the form of its coronavirus vaccine, other medicines with growing sales, and a rich pipeline to keep revenue sources coming, this pharma stock looks like a much better long-term bet than AMC or GameStop.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F617555%2Fgettyimages-1291715271.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images</p><p><b>2. Netflix</b></p><p>Netflix is already <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leading streaming video platforms in the world, but the company isn't done growing. What are the opportunities ahead for the tech giant? First, the company is looking to add even more users to its platform. As of its fourth quarter ending Dec. 31, the company had 8.51 million net new subscribers. It ended the period with a total of 203.7 million paid subscriptions, representing a year-over-year increase of 21.9%. Netflix thinks it will add 6 million new subscribers in the first quarter of 2021.</p><p>And the streaming services industry as a whole has a long runway for growth. According to Grand View Research, this market was worth 50.1 billion in 2020, and it is projected to expand at a compound annual growth rate (CAGR) of 21% between 2021 and 2028.</p><p>As one of the most recognizable names in this segment, Netflix is well-positioned to profit, especially since competing streaming platforms are more than capable of coexisting. One of the most powerful weapons in these platforms' arsenals is original content, and Netflix has been pouring money into original series and movies in the hopes of building a library people will want to keep coming back to.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F617555%2Fgettyimages-1174414330.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images.</p><p>These investments have played an important role in the company's success in recent years. Since the content on Netflix is different from that of some of its peers,&nbsp;many customers are more than happy to pay for subscriptions to several companies in this space. The long-term plan for Netflix is simple: Replace regular TV.</p><p>The company offers several advantages over cable: no ads, no long-term contracts, and on-demand movies and series streaming on any device. And while some cable providers have started to adapt to the new paradigm, Netflix is well on its way to continue its long winning streak in the streaming industry. Those factors make the company's stock worth a buy.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nForget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-16 23:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/><strong>Prosper Junior Bakiny</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BPOPM":"Popular","BPOPN":"Popular"},"source_url":"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2119619927","content_text":"The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the list of the 100 most popular stocks on the platform. However, some of the stocks on that list are head-scratchers. For instance, GameStop (NYSE:GME) and AMC Entertainment (NYSE:AMC) are among the top 20 most commonly held stocks on the app as of this writing.Both of these businesses are struggling, in part due to their reliance on brick-and-mortar operations, which were severely impacted by the pandemic. Further, both AMC and Gamestop were at the center of the now (in)famous short-squeeze fiasco orchestrated by traders from Reddit's r/WallStreetBets. Investors would be better off staying away from these two unpredictable companies and instead purchasing shares of Robinhood stocks with solid futures ahead of them. Two such companies worth considering are Pfizer (NYSE:PFE) and Netflix (NASDAQ:NFLX).^SPX data by YCharts1. PfizerYou've probably heard a lot about Pfizer in the past few months. The company and its partner, BioNTech, developed BNT162b2, and received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) in December, becoming the first authorized COVID-19 vaccine in the U.S. BNT162b2 has also been approved in the European Union.While Pfizer and BioNTech have to share the vaccine supply gameboard with several other companies, including Johnson & Johnson, AstraZeneca, and Moderna, the market (i.e., the entire world) is large enough for there to be multiple winners. In other words, BNT162b2 will contribute meaningfully to Pfizer's top line, especially since there is evidence of it being effective against some of the newer variants of the virus.But the company's lineup is much bigger than just this one vaccine. Some of Pfizer's top-performing products include anticoagulant Eliquis and cancer treatments Ibrance and Xtandi. Sales of Eliquis for fiscal year 2020 (ended Dec. 31) were $4.9 billion, a 17% year-over-year increase. Ibrance's revenue jumped by 9% year over year to $5.4 billion, while Xtandi's sales came in at roughly $1 billion, representing 22% growth from fiscal year 2019.Pfizer also boasts 95 programs in its pipeline, including 24 ongoing phase 3 studies. Pfizer is well-positioned to keep adding new revenue sources to its lineup every year. Lastly, it is worth noting that Pfizer spun-off its off-patent medicine unit Upjohn to the company formerly known as Mylan. The combined entity of Mylan and Upjohn is called Viatris, and it started trading on the market on Nov. 17.Pfizer decided to make this move because Upjohn's declining sales were hurting its bottom line. The company can now focus on its more profitable biopharma business. This focus should help Pfizer improve its financial results, which will help its stock recover from its underperformance relative to the market in the past year.With a more focused business, a short-term catalyst in the form of its coronavirus vaccine, other medicines with growing sales, and a rich pipeline to keep revenue sources coming, this pharma stock looks like a much better long-term bet than AMC or GameStop.Image source: Getty Images2. NetflixNetflix is already one of the leading streaming video platforms in the world, but the company isn't done growing. What are the opportunities ahead for the tech giant? First, the company is looking to add even more users to its platform. As of its fourth quarter ending Dec. 31, the company had 8.51 million net new subscribers. It ended the period with a total of 203.7 million paid subscriptions, representing a year-over-year increase of 21.9%. Netflix thinks it will add 6 million new subscribers in the first quarter of 2021.And the streaming services industry as a whole has a long runway for growth. According to Grand View Research, this market was worth 50.1 billion in 2020, and it is projected to expand at a compound annual growth rate (CAGR) of 21% between 2021 and 2028.As one of the most recognizable names in this segment, Netflix is well-positioned to profit, especially since competing streaming platforms are more than capable of coexisting. One of the most powerful weapons in these platforms' arsenals is original content, and Netflix has been pouring money into original series and movies in the hopes of building a library people will want to keep coming back to.Image source: Getty Images.These investments have played an important role in the company's success in recent years. Since the content on Netflix is different from that of some of its peers, many customers are more than happy to pay for subscriptions to several companies in this space. The long-term plan for Netflix is simple: Replace regular TV.The company offers several advantages over cable: no ads, no long-term contracts, and on-demand movies and series streaming on any device. And while some cable providers have started to adapt to the new paradigm, Netflix is well on its way to continue its long winning streak in the streaming industry. Those factors make the company's stock worth a buy.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":3811825,"gmtCreate":1615937167102,"gmtModify":1635753497179,"authorId":3570935856611684,"author":{"id":3570935856611684,"authorId":3570935856611684,"name":"ZelHo","avatar":"https://static.tigerbbs.com/3c37663c3ab4dacc6660d2f9f671a07a","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":325712374,"type":1,"supId":0,"prevId":0,"content":"Yes","text":"Yes","html":"Yes"},{"id":3830924,"gmtCreate":1616108853233,"gmtModify":1635752455751,"authorId":3575267591947467,"author":{"id":3575267591947467,"authorId":3575267591947467,"name":"Nicolas_Lim_","avatar":"https://static.tigerbbs.com/81814c9fedb93438bfff33b7876bf7ce","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":325712374,"type":1,"supId":0,"prevId":0,"content":"yes","text":"yes","html":"yes"},{"id":3845456,"gmtCreate":1616300741274,"gmtModify":1635751484758,"authorId":3576021125565845,"author":{"id":3576021125565845,"authorId":3576021125565845,"name":"Kuxn","avatar":"https://static.tigerbbs.com/735264c1e1b135b6b4b9925b858173c7","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":325712374,"type":1,"supId":3830924,"prevId":0,"content":"HAAHAHA CB","text":"HAAHAHA CB","html":"HAAHAHA CB"}],"langContent":"EN"},{"id":325718977,"gmtCreate":1615936687499,"gmtModify":1703495153966,"author":{"id":"3577278649305758","authorId":"3577278649305758","name":"kawa86","avatar":"https://static.tigerbbs.com/cb30220b2a555e9c653be64d2421ff9c","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"buy buy buy","listText":"buy buy buy","text":"buy buy buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/325718977","repostId":2119619927,"repostType":4,"repost":{"id":"2119619927","pubTimestamp":1615907700,"share":"https://www.laohu8.com/m/news/2119619927?lang=&edition=full","pubTime":"2021-03-16 23:15","market":"us","language":"en","title":"Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys","url":"https://stock-news.laohu8.com/highlight/detail?id=2119619927","media":"Prosper Junior Bakiny","summary":"No need to invest in faltering businesses -- these two winning companies are better bets.","content":"<p>The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the list of the 100 most popular stocks on the platform. However, some of the stocks on that list are head-scratchers. For instance, <b>GameStop</b> (NYSE:GME) and <b>AMC Entertainment</b> (NYSE:AMC) are among the top 20 most commonly held stocks on the app as of this writing.</p><p>Both of these businesses are struggling, in part due to their reliance on brick-and-mortar operations, which were severely impacted by the pandemic. Further, both AMC and Gamestop were at the center of the now (in)famous short-squeeze fiasco orchestrated by traders from Reddit's r/WallStreetBets. Investors would be better off staying away from these two unpredictable companies and instead purchasing shares of Robinhood stocks with solid futures ahead of them. Two such companies worth considering are <b>Pfizer</b> (NYSE:PFE) and <b>Netflix</b> (NASDAQ:NFLX).</p><p><img src=\"https://media.ycharts.com/charts/693c6b3570e5dc157db6f1cb5d80481e.png\" tg-width=\"720\" tg-height=\"387\" referrerpolicy=\"no-referrer\"></p><p>^SPX data by YCharts</p><p><b>1. Pfizer</b></p><p>You've probably heard a lot about Pfizer in the past few months. The company and its partner, <b>BioNTech</b>, developed BNT162b2, and received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) in December, becoming the first authorized COVID-19 vaccine in the U.S. BNT162b2 has also been approved in the European Union.</p><p>While Pfizer and BioNTech have to share the vaccine supply gameboard with several other companies, including <b>Johnson &amp; Johnson</b>, <b>AstraZeneca</b>, and <b>Moderna</b>, the market (i.e., the entire world) is large enough for there to be multiple winners. In other words, BNT162b2 will contribute meaningfully to Pfizer's top line, especially since there is evidence of it being effective against some of the newer variants of the virus.</p><p>But the company's lineup is much bigger than just this <a href=\"https://laohu8.com/S/AONE\">one</a> vaccine. Some of Pfizer's top-performing products include anticoagulant Eliquis and cancer treatments Ibrance and Xtandi. Sales of Eliquis for fiscal year 2020 (ended Dec. 31) were $4.9 billion, a 17% year-over-year increase. Ibrance's revenue jumped by 9% year over year to $5.4 billion, while Xtandi's sales came in at roughly $1 billion, representing 22% growth from fiscal year 2019.</p><p>Pfizer also boasts 95 programs in its pipeline, including 24 ongoing phase 3 studies. Pfizer is well-positioned to keep adding new revenue sources to its lineup every year. Lastly, it is worth noting that Pfizer spun-off its off-patent medicine unit Upjohn to the company formerly known as Mylan. The combined entity of Mylan and Upjohn is called <b>Viatris</b>, and it started trading on the market on Nov. 17.</p><p>Pfizer decided to make this move because Upjohn's declining sales were hurting its bottom line. The company can now focus on its more profitable biopharma business. This focus should help Pfizer improve its financial results, which will help its stock recover from its underperformance relative to the market in the past year.</p><p>With a more focused business, a short-term catalyst in the form of its coronavirus vaccine, other medicines with growing sales, and a rich pipeline to keep revenue sources coming, this pharma stock looks like a much better long-term bet than AMC or GameStop.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F617555%2Fgettyimages-1291715271.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images</p><p><b>2. Netflix</b></p><p>Netflix is already <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leading streaming video platforms in the world, but the company isn't done growing. What are the opportunities ahead for the tech giant? First, the company is looking to add even more users to its platform. As of its fourth quarter ending Dec. 31, the company had 8.51 million net new subscribers. It ended the period with a total of 203.7 million paid subscriptions, representing a year-over-year increase of 21.9%. Netflix thinks it will add 6 million new subscribers in the first quarter of 2021.</p><p>And the streaming services industry as a whole has a long runway for growth. According to Grand View Research, this market was worth 50.1 billion in 2020, and it is projected to expand at a compound annual growth rate (CAGR) of 21% between 2021 and 2028.</p><p>As one of the most recognizable names in this segment, Netflix is well-positioned to profit, especially since competing streaming platforms are more than capable of coexisting. One of the most powerful weapons in these platforms' arsenals is original content, and Netflix has been pouring money into original series and movies in the hopes of building a library people will want to keep coming back to.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F617555%2Fgettyimages-1174414330.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images.</p><p>These investments have played an important role in the company's success in recent years. Since the content on Netflix is different from that of some of its peers,&nbsp;many customers are more than happy to pay for subscriptions to several companies in this space. The long-term plan for Netflix is simple: Replace regular TV.</p><p>The company offers several advantages over cable: no ads, no long-term contracts, and on-demand movies and series streaming on any device. And while some cable providers have started to adapt to the new paradigm, Netflix is well on its way to continue its long winning streak in the streaming industry. Those factors make the company's stock worth a buy.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nForget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-16 23:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/><strong>Prosper Junior Bakiny</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BPOPM":"Popular","BPOPN":"Popular"},"source_url":"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2119619927","content_text":"The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the list of the 100 most popular stocks on the platform. However, some of the stocks on that list are head-scratchers. For instance, GameStop (NYSE:GME) and AMC Entertainment (NYSE:AMC) are among the top 20 most commonly held stocks on the app as of this writing.Both of these businesses are struggling, in part due to their reliance on brick-and-mortar operations, which were severely impacted by the pandemic. Further, both AMC and Gamestop were at the center of the now (in)famous short-squeeze fiasco orchestrated by traders from Reddit's r/WallStreetBets. Investors would be better off staying away from these two unpredictable companies and instead purchasing shares of Robinhood stocks with solid futures ahead of them. Two such companies worth considering are Pfizer (NYSE:PFE) and Netflix (NASDAQ:NFLX).^SPX data by YCharts1. PfizerYou've probably heard a lot about Pfizer in the past few months. The company and its partner, BioNTech, developed BNT162b2, and received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) in December, becoming the first authorized COVID-19 vaccine in the U.S. BNT162b2 has also been approved in the European Union.While Pfizer and BioNTech have to share the vaccine supply gameboard with several other companies, including Johnson & Johnson, AstraZeneca, and Moderna, the market (i.e., the entire world) is large enough for there to be multiple winners. In other words, BNT162b2 will contribute meaningfully to Pfizer's top line, especially since there is evidence of it being effective against some of the newer variants of the virus.But the company's lineup is much bigger than just this one vaccine. Some of Pfizer's top-performing products include anticoagulant Eliquis and cancer treatments Ibrance and Xtandi. Sales of Eliquis for fiscal year 2020 (ended Dec. 31) were $4.9 billion, a 17% year-over-year increase. Ibrance's revenue jumped by 9% year over year to $5.4 billion, while Xtandi's sales came in at roughly $1 billion, representing 22% growth from fiscal year 2019.Pfizer also boasts 95 programs in its pipeline, including 24 ongoing phase 3 studies. Pfizer is well-positioned to keep adding new revenue sources to its lineup every year. Lastly, it is worth noting that Pfizer spun-off its off-patent medicine unit Upjohn to the company formerly known as Mylan. The combined entity of Mylan and Upjohn is called Viatris, and it started trading on the market on Nov. 17.Pfizer decided to make this move because Upjohn's declining sales were hurting its bottom line. The company can now focus on its more profitable biopharma business. This focus should help Pfizer improve its financial results, which will help its stock recover from its underperformance relative to the market in the past year.With a more focused business, a short-term catalyst in the form of its coronavirus vaccine, other medicines with growing sales, and a rich pipeline to keep revenue sources coming, this pharma stock looks like a much better long-term bet than AMC or GameStop.Image source: Getty Images2. NetflixNetflix is already one of the leading streaming video platforms in the world, but the company isn't done growing. What are the opportunities ahead for the tech giant? First, the company is looking to add even more users to its platform. As of its fourth quarter ending Dec. 31, the company had 8.51 million net new subscribers. It ended the period with a total of 203.7 million paid subscriptions, representing a year-over-year increase of 21.9%. Netflix thinks it will add 6 million new subscribers in the first quarter of 2021.And the streaming services industry as a whole has a long runway for growth. According to Grand View Research, this market was worth 50.1 billion in 2020, and it is projected to expand at a compound annual growth rate (CAGR) of 21% between 2021 and 2028.As one of the most recognizable names in this segment, Netflix is well-positioned to profit, especially since competing streaming platforms are more than capable of coexisting. One of the most powerful weapons in these platforms' arsenals is original content, and Netflix has been pouring money into original series and movies in the hopes of building a library people will want to keep coming back to.Image source: Getty Images.These investments have played an important role in the company's success in recent years. Since the content on Netflix is different from that of some of its peers, many customers are more than happy to pay for subscriptions to several companies in this space. The long-term plan for Netflix is simple: Replace regular TV.The company offers several advantages over cable: no ads, no long-term contracts, and on-demand movies and series streaming on any device. And while some cable providers have started to adapt to the new paradigm, Netflix is well on its way to continue its long winning streak in the streaming industry. Those factors make the company's stock worth a buy.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":3811784,"gmtCreate":1615936834142,"gmtModify":1635753500008,"authorId":3577278649305758,"author":{"id":3577278649305758,"authorId":3577278649305758,"name":"kawa86","avatar":"https://static.tigerbbs.com/cb30220b2a555e9c653be64d2421ff9c","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":325718977,"type":1,"supId":0,"prevId":0,"content":"like &amp; <u>comment</u>","text":"like &amp; <u>comment</u>","html":"like &amp; <u>comment</u>"}],"langContent":"EN"},{"id":325711383,"gmtCreate":1615936616142,"gmtModify":1703495152405,"author":{"id":"3560241002253187","authorId":"3560241002253187","name":"CL777","avatar":"https://static.tigerbbs.com/e9aef3dd830373a0427a3447b1b564e3","vip":1,"crmLevel":6,"crmLevelSwitch":0},"htmlText":"More gambling?","listText":"More gambling?","text":"More gambling?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/325711383","repostId":2119619927,"repostType":4,"repost":{"id":"2119619927","pubTimestamp":1615907700,"share":"https://www.laohu8.com/m/news/2119619927?lang=&edition=full","pubTime":"2021-03-16 23:15","market":"us","language":"en","title":"Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys","url":"https://stock-news.laohu8.com/highlight/detail?id=2119619927","media":"Prosper Junior Bakiny","summary":"No need to invest in faltering businesses -- these two winning companies are better bets.","content":"<p>The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the list of the 100 most popular stocks on the platform. However, some of the stocks on that list are head-scratchers. For instance, <b>GameStop</b> (NYSE:GME) and <b>AMC Entertainment</b> (NYSE:AMC) are among the top 20 most commonly held stocks on the app as of this writing.</p><p>Both of these businesses are struggling, in part due to their reliance on brick-and-mortar operations, which were severely impacted by the pandemic. Further, both AMC and Gamestop were at the center of the now (in)famous short-squeeze fiasco orchestrated by traders from Reddit's r/WallStreetBets. Investors would be better off staying away from these two unpredictable companies and instead purchasing shares of Robinhood stocks with solid futures ahead of them. Two such companies worth considering are <b>Pfizer</b> (NYSE:PFE) and <b>Netflix</b> (NASDAQ:NFLX).</p><p><img src=\"https://media.ycharts.com/charts/693c6b3570e5dc157db6f1cb5d80481e.png\" tg-width=\"720\" tg-height=\"387\" referrerpolicy=\"no-referrer\"></p><p>^SPX data by YCharts</p><p><b>1. Pfizer</b></p><p>You've probably heard a lot about Pfizer in the past few months. The company and its partner, <b>BioNTech</b>, developed BNT162b2, and received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) in December, becoming the first authorized COVID-19 vaccine in the U.S. BNT162b2 has also been approved in the European Union.</p><p>While Pfizer and BioNTech have to share the vaccine supply gameboard with several other companies, including <b>Johnson &amp; Johnson</b>, <b>AstraZeneca</b>, and <b>Moderna</b>, the market (i.e., the entire world) is large enough for there to be multiple winners. In other words, BNT162b2 will contribute meaningfully to Pfizer's top line, especially since there is evidence of it being effective against some of the newer variants of the virus.</p><p>But the company's lineup is much bigger than just this <a href=\"https://laohu8.com/S/AONE\">one</a> vaccine. Some of Pfizer's top-performing products include anticoagulant Eliquis and cancer treatments Ibrance and Xtandi. Sales of Eliquis for fiscal year 2020 (ended Dec. 31) were $4.9 billion, a 17% year-over-year increase. Ibrance's revenue jumped by 9% year over year to $5.4 billion, while Xtandi's sales came in at roughly $1 billion, representing 22% growth from fiscal year 2019.</p><p>Pfizer also boasts 95 programs in its pipeline, including 24 ongoing phase 3 studies. Pfizer is well-positioned to keep adding new revenue sources to its lineup every year. Lastly, it is worth noting that Pfizer spun-off its off-patent medicine unit Upjohn to the company formerly known as Mylan. The combined entity of Mylan and Upjohn is called <b>Viatris</b>, and it started trading on the market on Nov. 17.</p><p>Pfizer decided to make this move because Upjohn's declining sales were hurting its bottom line. The company can now focus on its more profitable biopharma business. This focus should help Pfizer improve its financial results, which will help its stock recover from its underperformance relative to the market in the past year.</p><p>With a more focused business, a short-term catalyst in the form of its coronavirus vaccine, other medicines with growing sales, and a rich pipeline to keep revenue sources coming, this pharma stock looks like a much better long-term bet than AMC or GameStop.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F617555%2Fgettyimages-1291715271.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images</p><p><b>2. Netflix</b></p><p>Netflix is already <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leading streaming video platforms in the world, but the company isn't done growing. What are the opportunities ahead for the tech giant? First, the company is looking to add even more users to its platform. As of its fourth quarter ending Dec. 31, the company had 8.51 million net new subscribers. It ended the period with a total of 203.7 million paid subscriptions, representing a year-over-year increase of 21.9%. Netflix thinks it will add 6 million new subscribers in the first quarter of 2021.</p><p>And the streaming services industry as a whole has a long runway for growth. According to Grand View Research, this market was worth 50.1 billion in 2020, and it is projected to expand at a compound annual growth rate (CAGR) of 21% between 2021 and 2028.</p><p>As one of the most recognizable names in this segment, Netflix is well-positioned to profit, especially since competing streaming platforms are more than capable of coexisting. One of the most powerful weapons in these platforms' arsenals is original content, and Netflix has been pouring money into original series and movies in the hopes of building a library people will want to keep coming back to.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F617555%2Fgettyimages-1174414330.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images.</p><p>These investments have played an important role in the company's success in recent years. Since the content on Netflix is different from that of some of its peers,&nbsp;many customers are more than happy to pay for subscriptions to several companies in this space. The long-term plan for Netflix is simple: Replace regular TV.</p><p>The company offers several advantages over cable: no ads, no long-term contracts, and on-demand movies and series streaming on any device. And while some cable providers have started to adapt to the new paradigm, Netflix is well on its way to continue its long winning streak in the streaming industry. Those factors make the company's stock worth a buy.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nForget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-16 23:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/><strong>Prosper Junior Bakiny</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BPOPM":"Popular","BPOPN":"Popular"},"source_url":"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2119619927","content_text":"The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the list of the 100 most popular stocks on the platform. However, some of the stocks on that list are head-scratchers. For instance, GameStop (NYSE:GME) and AMC Entertainment (NYSE:AMC) are among the top 20 most commonly held stocks on the app as of this writing.Both of these businesses are struggling, in part due to their reliance on brick-and-mortar operations, which were severely impacted by the pandemic. Further, both AMC and Gamestop were at the center of the now (in)famous short-squeeze fiasco orchestrated by traders from Reddit's r/WallStreetBets. Investors would be better off staying away from these two unpredictable companies and instead purchasing shares of Robinhood stocks with solid futures ahead of them. Two such companies worth considering are Pfizer (NYSE:PFE) and Netflix (NASDAQ:NFLX).^SPX data by YCharts1. PfizerYou've probably heard a lot about Pfizer in the past few months. The company and its partner, BioNTech, developed BNT162b2, and received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) in December, becoming the first authorized COVID-19 vaccine in the U.S. BNT162b2 has also been approved in the European Union.While Pfizer and BioNTech have to share the vaccine supply gameboard with several other companies, including Johnson & Johnson, AstraZeneca, and Moderna, the market (i.e., the entire world) is large enough for there to be multiple winners. In other words, BNT162b2 will contribute meaningfully to Pfizer's top line, especially since there is evidence of it being effective against some of the newer variants of the virus.But the company's lineup is much bigger than just this one vaccine. Some of Pfizer's top-performing products include anticoagulant Eliquis and cancer treatments Ibrance and Xtandi. Sales of Eliquis for fiscal year 2020 (ended Dec. 31) were $4.9 billion, a 17% year-over-year increase. Ibrance's revenue jumped by 9% year over year to $5.4 billion, while Xtandi's sales came in at roughly $1 billion, representing 22% growth from fiscal year 2019.Pfizer also boasts 95 programs in its pipeline, including 24 ongoing phase 3 studies. Pfizer is well-positioned to keep adding new revenue sources to its lineup every year. Lastly, it is worth noting that Pfizer spun-off its off-patent medicine unit Upjohn to the company formerly known as Mylan. The combined entity of Mylan and Upjohn is called Viatris, and it started trading on the market on Nov. 17.Pfizer decided to make this move because Upjohn's declining sales were hurting its bottom line. The company can now focus on its more profitable biopharma business. This focus should help Pfizer improve its financial results, which will help its stock recover from its underperformance relative to the market in the past year.With a more focused business, a short-term catalyst in the form of its coronavirus vaccine, other medicines with growing sales, and a rich pipeline to keep revenue sources coming, this pharma stock looks like a much better long-term bet than AMC or GameStop.Image source: Getty Images2. NetflixNetflix is already one of the leading streaming video platforms in the world, but the company isn't done growing. What are the opportunities ahead for the tech giant? First, the company is looking to add even more users to its platform. As of its fourth quarter ending Dec. 31, the company had 8.51 million net new subscribers. It ended the period with a total of 203.7 million paid subscriptions, representing a year-over-year increase of 21.9%. Netflix thinks it will add 6 million new subscribers in the first quarter of 2021.And the streaming services industry as a whole has a long runway for growth. According to Grand View Research, this market was worth 50.1 billion in 2020, and it is projected to expand at a compound annual growth rate (CAGR) of 21% between 2021 and 2028.As one of the most recognizable names in this segment, Netflix is well-positioned to profit, especially since competing streaming platforms are more than capable of coexisting. One of the most powerful weapons in these platforms' arsenals is original content, and Netflix has been pouring money into original series and movies in the hopes of building a library people will want to keep coming back to.Image source: Getty Images.These investments have played an important role in the company's success in recent years. Since the content on Netflix is different from that of some of its peers, many customers are more than happy to pay for subscriptions to several companies in this space. The long-term plan for Netflix is simple: Replace regular TV.The company offers several advantages over cable: no ads, no long-term contracts, and on-demand movies and series streaming on any device. And while some cable providers have started to adapt to the new paradigm, Netflix is well on its way to continue its long winning streak in the streaming industry. Those factors make the company's stock worth a buy.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":325798092,"gmtCreate":1615934114316,"gmtModify":1703495126468,"author":{"id":"3572824646640760","authorId":"3572824646640760","name":"Haohao2324","avatar":"https://static.tigerbbs.com/5741ee0bde82c7782d814be80e181a3e","vip":1,"crmLevel":4,"crmLevelSwitch":0},"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/325798092","repostId":2119619927,"repostType":4,"repost":{"id":"2119619927","pubTimestamp":1615907700,"share":"https://www.laohu8.com/m/news/2119619927?lang=&edition=full","pubTime":"2021-03-16 23:15","market":"us","language":"en","title":"Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys","url":"https://stock-news.laohu8.com/highlight/detail?id=2119619927","media":"Prosper Junior Bakiny","summary":"No need to invest in faltering businesses -- these two winning companies are better bets.","content":"<p>The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the list of the 100 most popular stocks on the platform. However, some of the stocks on that list are head-scratchers. For instance, <b>GameStop</b> (NYSE:GME) and <b>AMC Entertainment</b> (NYSE:AMC) are among the top 20 most commonly held stocks on the app as of this writing.</p><p>Both of these businesses are struggling, in part due to their reliance on brick-and-mortar operations, which were severely impacted by the pandemic. Further, both AMC and Gamestop were at the center of the now (in)famous short-squeeze fiasco orchestrated by traders from Reddit's r/WallStreetBets. Investors would be better off staying away from these two unpredictable companies and instead purchasing shares of Robinhood stocks with solid futures ahead of them. Two such companies worth considering are <b>Pfizer</b> (NYSE:PFE) and <b>Netflix</b> (NASDAQ:NFLX).</p><p><img src=\"https://media.ycharts.com/charts/693c6b3570e5dc157db6f1cb5d80481e.png\" tg-width=\"720\" tg-height=\"387\" referrerpolicy=\"no-referrer\"></p><p>^SPX data by YCharts</p><p><b>1. Pfizer</b></p><p>You've probably heard a lot about Pfizer in the past few months. The company and its partner, <b>BioNTech</b>, developed BNT162b2, and received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) in December, becoming the first authorized COVID-19 vaccine in the U.S. BNT162b2 has also been approved in the European Union.</p><p>While Pfizer and BioNTech have to share the vaccine supply gameboard with several other companies, including <b>Johnson &amp; Johnson</b>, <b>AstraZeneca</b>, and <b>Moderna</b>, the market (i.e., the entire world) is large enough for there to be multiple winners. In other words, BNT162b2 will contribute meaningfully to Pfizer's top line, especially since there is evidence of it being effective against some of the newer variants of the virus.</p><p>But the company's lineup is much bigger than just this <a href=\"https://laohu8.com/S/AONE\">one</a> vaccine. Some of Pfizer's top-performing products include anticoagulant Eliquis and cancer treatments Ibrance and Xtandi. Sales of Eliquis for fiscal year 2020 (ended Dec. 31) were $4.9 billion, a 17% year-over-year increase. Ibrance's revenue jumped by 9% year over year to $5.4 billion, while Xtandi's sales came in at roughly $1 billion, representing 22% growth from fiscal year 2019.</p><p>Pfizer also boasts 95 programs in its pipeline, including 24 ongoing phase 3 studies. Pfizer is well-positioned to keep adding new revenue sources to its lineup every year. Lastly, it is worth noting that Pfizer spun-off its off-patent medicine unit Upjohn to the company formerly known as Mylan. The combined entity of Mylan and Upjohn is called <b>Viatris</b>, and it started trading on the market on Nov. 17.</p><p>Pfizer decided to make this move because Upjohn's declining sales were hurting its bottom line. The company can now focus on its more profitable biopharma business. This focus should help Pfizer improve its financial results, which will help its stock recover from its underperformance relative to the market in the past year.</p><p>With a more focused business, a short-term catalyst in the form of its coronavirus vaccine, other medicines with growing sales, and a rich pipeline to keep revenue sources coming, this pharma stock looks like a much better long-term bet than AMC or GameStop.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F617555%2Fgettyimages-1291715271.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images</p><p><b>2. Netflix</b></p><p>Netflix is already <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leading streaming video platforms in the world, but the company isn't done growing. What are the opportunities ahead for the tech giant? First, the company is looking to add even more users to its platform. As of its fourth quarter ending Dec. 31, the company had 8.51 million net new subscribers. It ended the period with a total of 203.7 million paid subscriptions, representing a year-over-year increase of 21.9%. Netflix thinks it will add 6 million new subscribers in the first quarter of 2021.</p><p>And the streaming services industry as a whole has a long runway for growth. According to Grand View Research, this market was worth 50.1 billion in 2020, and it is projected to expand at a compound annual growth rate (CAGR) of 21% between 2021 and 2028.</p><p>As one of the most recognizable names in this segment, Netflix is well-positioned to profit, especially since competing streaming platforms are more than capable of coexisting. One of the most powerful weapons in these platforms' arsenals is original content, and Netflix has been pouring money into original series and movies in the hopes of building a library people will want to keep coming back to.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F617555%2Fgettyimages-1174414330.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images.</p><p>These investments have played an important role in the company's success in recent years. Since the content on Netflix is different from that of some of its peers,&nbsp;many customers are more than happy to pay for subscriptions to several companies in this space. The long-term plan for Netflix is simple: Replace regular TV.</p><p>The company offers several advantages over cable: no ads, no long-term contracts, and on-demand movies and series streaming on any device. And while some cable providers have started to adapt to the new paradigm, Netflix is well on its way to continue its long winning streak in the streaming industry. Those factors make the company's stock worth a buy.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nForget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-16 23:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/><strong>Prosper Junior Bakiny</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BPOPM":"Popular","BPOPN":"Popular"},"source_url":"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2119619927","content_text":"The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the list of the 100 most popular stocks on the platform. However, some of the stocks on that list are head-scratchers. For instance, GameStop (NYSE:GME) and AMC Entertainment (NYSE:AMC) are among the top 20 most commonly held stocks on the app as of this writing.Both of these businesses are struggling, in part due to their reliance on brick-and-mortar operations, which were severely impacted by the pandemic. Further, both AMC and Gamestop were at the center of the now (in)famous short-squeeze fiasco orchestrated by traders from Reddit's r/WallStreetBets. Investors would be better off staying away from these two unpredictable companies and instead purchasing shares of Robinhood stocks with solid futures ahead of them. Two such companies worth considering are Pfizer (NYSE:PFE) and Netflix (NASDAQ:NFLX).^SPX data by YCharts1. PfizerYou've probably heard a lot about Pfizer in the past few months. The company and its partner, BioNTech, developed BNT162b2, and received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) in December, becoming the first authorized COVID-19 vaccine in the U.S. BNT162b2 has also been approved in the European Union.While Pfizer and BioNTech have to share the vaccine supply gameboard with several other companies, including Johnson & Johnson, AstraZeneca, and Moderna, the market (i.e., the entire world) is large enough for there to be multiple winners. In other words, BNT162b2 will contribute meaningfully to Pfizer's top line, especially since there is evidence of it being effective against some of the newer variants of the virus.But the company's lineup is much bigger than just this one vaccine. Some of Pfizer's top-performing products include anticoagulant Eliquis and cancer treatments Ibrance and Xtandi. Sales of Eliquis for fiscal year 2020 (ended Dec. 31) were $4.9 billion, a 17% year-over-year increase. Ibrance's revenue jumped by 9% year over year to $5.4 billion, while Xtandi's sales came in at roughly $1 billion, representing 22% growth from fiscal year 2019.Pfizer also boasts 95 programs in its pipeline, including 24 ongoing phase 3 studies. Pfizer is well-positioned to keep adding new revenue sources to its lineup every year. Lastly, it is worth noting that Pfizer spun-off its off-patent medicine unit Upjohn to the company formerly known as Mylan. The combined entity of Mylan and Upjohn is called Viatris, and it started trading on the market on Nov. 17.Pfizer decided to make this move because Upjohn's declining sales were hurting its bottom line. The company can now focus on its more profitable biopharma business. This focus should help Pfizer improve its financial results, which will help its stock recover from its underperformance relative to the market in the past year.With a more focused business, a short-term catalyst in the form of its coronavirus vaccine, other medicines with growing sales, and a rich pipeline to keep revenue sources coming, this pharma stock looks like a much better long-term bet than AMC or GameStop.Image source: Getty Images2. NetflixNetflix is already one of the leading streaming video platforms in the world, but the company isn't done growing. What are the opportunities ahead for the tech giant? First, the company is looking to add even more users to its platform. As of its fourth quarter ending Dec. 31, the company had 8.51 million net new subscribers. It ended the period with a total of 203.7 million paid subscriptions, representing a year-over-year increase of 21.9%. Netflix thinks it will add 6 million new subscribers in the first quarter of 2021.And the streaming services industry as a whole has a long runway for growth. According to Grand View Research, this market was worth 50.1 billion in 2020, and it is projected to expand at a compound annual growth rate (CAGR) of 21% between 2021 and 2028.As one of the most recognizable names in this segment, Netflix is well-positioned to profit, especially since competing streaming platforms are more than capable of coexisting. One of the most powerful weapons in these platforms' arsenals is original content, and Netflix has been pouring money into original series and movies in the hopes of building a library people will want to keep coming back to.Image source: Getty Images.These investments have played an important role in the company's success in recent years. Since the content on Netflix is different from that of some of its peers, many customers are more than happy to pay for subscriptions to several companies in this space. The long-term plan for Netflix is simple: Replace regular TV.The company offers several advantages over cable: no ads, no long-term contracts, and on-demand movies and series streaming on any device. And while some cable providers have started to adapt to the new paradigm, Netflix is well on its way to continue its long winning streak in the streaming industry. Those factors make the company's stock worth a buy.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":325799410,"gmtCreate":1615933702130,"gmtModify":1703495123838,"author":{"id":"3575186483172193","authorId":"3575186483172193","name":"Tarnek","avatar":"https://static.tigerbbs.com/1599cd0c9b49c0dc3f2d88b0f0086944","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"buy buy buy","listText":"buy buy buy","text":"buy buy buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/325799410","repostId":2119619927,"repostType":4,"repost":{"id":"2119619927","pubTimestamp":1615907700,"share":"https://www.laohu8.com/m/news/2119619927?lang=&edition=full","pubTime":"2021-03-16 23:15","market":"us","language":"en","title":"Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys","url":"https://stock-news.laohu8.com/highlight/detail?id=2119619927","media":"Prosper Junior Bakiny","summary":"No need to invest in faltering businesses -- these two winning companies are better bets.","content":"<p>The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the list of the 100 most popular stocks on the platform. However, some of the stocks on that list are head-scratchers. For instance, <b>GameStop</b> (NYSE:GME) and <b>AMC Entertainment</b> (NYSE:AMC) are among the top 20 most commonly held stocks on the app as of this writing.</p><p>Both of these businesses are struggling, in part due to their reliance on brick-and-mortar operations, which were severely impacted by the pandemic. Further, both AMC and Gamestop were at the center of the now (in)famous short-squeeze fiasco orchestrated by traders from Reddit's r/WallStreetBets. Investors would be better off staying away from these two unpredictable companies and instead purchasing shares of Robinhood stocks with solid futures ahead of them. Two such companies worth considering are <b>Pfizer</b> (NYSE:PFE) and <b>Netflix</b> (NASDAQ:NFLX).</p><p><img src=\"https://media.ycharts.com/charts/693c6b3570e5dc157db6f1cb5d80481e.png\" tg-width=\"720\" tg-height=\"387\" referrerpolicy=\"no-referrer\"></p><p>^SPX data by YCharts</p><p><b>1. Pfizer</b></p><p>You've probably heard a lot about Pfizer in the past few months. The company and its partner, <b>BioNTech</b>, developed BNT162b2, and received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) in December, becoming the first authorized COVID-19 vaccine in the U.S. BNT162b2 has also been approved in the European Union.</p><p>While Pfizer and BioNTech have to share the vaccine supply gameboard with several other companies, including <b>Johnson &amp; Johnson</b>, <b>AstraZeneca</b>, and <b>Moderna</b>, the market (i.e., the entire world) is large enough for there to be multiple winners. In other words, BNT162b2 will contribute meaningfully to Pfizer's top line, especially since there is evidence of it being effective against some of the newer variants of the virus.</p><p>But the company's lineup is much bigger than just this <a href=\"https://laohu8.com/S/AONE\">one</a> vaccine. Some of Pfizer's top-performing products include anticoagulant Eliquis and cancer treatments Ibrance and Xtandi. Sales of Eliquis for fiscal year 2020 (ended Dec. 31) were $4.9 billion, a 17% year-over-year increase. Ibrance's revenue jumped by 9% year over year to $5.4 billion, while Xtandi's sales came in at roughly $1 billion, representing 22% growth from fiscal year 2019.</p><p>Pfizer also boasts 95 programs in its pipeline, including 24 ongoing phase 3 studies. Pfizer is well-positioned to keep adding new revenue sources to its lineup every year. Lastly, it is worth noting that Pfizer spun-off its off-patent medicine unit Upjohn to the company formerly known as Mylan. The combined entity of Mylan and Upjohn is called <b>Viatris</b>, and it started trading on the market on Nov. 17.</p><p>Pfizer decided to make this move because Upjohn's declining sales were hurting its bottom line. The company can now focus on its more profitable biopharma business. This focus should help Pfizer improve its financial results, which will help its stock recover from its underperformance relative to the market in the past year.</p><p>With a more focused business, a short-term catalyst in the form of its coronavirus vaccine, other medicines with growing sales, and a rich pipeline to keep revenue sources coming, this pharma stock looks like a much better long-term bet than AMC or GameStop.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F617555%2Fgettyimages-1291715271.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images</p><p><b>2. Netflix</b></p><p>Netflix is already <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leading streaming video platforms in the world, but the company isn't done growing. What are the opportunities ahead for the tech giant? First, the company is looking to add even more users to its platform. As of its fourth quarter ending Dec. 31, the company had 8.51 million net new subscribers. It ended the period with a total of 203.7 million paid subscriptions, representing a year-over-year increase of 21.9%. Netflix thinks it will add 6 million new subscribers in the first quarter of 2021.</p><p>And the streaming services industry as a whole has a long runway for growth. According to Grand View Research, this market was worth 50.1 billion in 2020, and it is projected to expand at a compound annual growth rate (CAGR) of 21% between 2021 and 2028.</p><p>As one of the most recognizable names in this segment, Netflix is well-positioned to profit, especially since competing streaming platforms are more than capable of coexisting. One of the most powerful weapons in these platforms' arsenals is original content, and Netflix has been pouring money into original series and movies in the hopes of building a library people will want to keep coming back to.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F617555%2Fgettyimages-1174414330.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images.</p><p>These investments have played an important role in the company's success in recent years. Since the content on Netflix is different from that of some of its peers,&nbsp;many customers are more than happy to pay for subscriptions to several companies in this space. The long-term plan for Netflix is simple: Replace regular TV.</p><p>The company offers several advantages over cable: no ads, no long-term contracts, and on-demand movies and series streaming on any device. And while some cable providers have started to adapt to the new paradigm, Netflix is well on its way to continue its long winning streak in the streaming industry. Those factors make the company's stock worth a buy.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nForget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-16 23:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/><strong>Prosper Junior Bakiny</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BPOPM":"Popular","BPOPN":"Popular"},"source_url":"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2119619927","content_text":"The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the list of the 100 most popular stocks on the platform. However, some of the stocks on that list are head-scratchers. For instance, GameStop (NYSE:GME) and AMC Entertainment (NYSE:AMC) are among the top 20 most commonly held stocks on the app as of this writing.Both of these businesses are struggling, in part due to their reliance on brick-and-mortar operations, which were severely impacted by the pandemic. Further, both AMC and Gamestop were at the center of the now (in)famous short-squeeze fiasco orchestrated by traders from Reddit's r/WallStreetBets. Investors would be better off staying away from these two unpredictable companies and instead purchasing shares of Robinhood stocks with solid futures ahead of them. Two such companies worth considering are Pfizer (NYSE:PFE) and Netflix (NASDAQ:NFLX).^SPX data by YCharts1. PfizerYou've probably heard a lot about Pfizer in the past few months. The company and its partner, BioNTech, developed BNT162b2, and received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) in December, becoming the first authorized COVID-19 vaccine in the U.S. BNT162b2 has also been approved in the European Union.While Pfizer and BioNTech have to share the vaccine supply gameboard with several other companies, including Johnson & Johnson, AstraZeneca, and Moderna, the market (i.e., the entire world) is large enough for there to be multiple winners. In other words, BNT162b2 will contribute meaningfully to Pfizer's top line, especially since there is evidence of it being effective against some of the newer variants of the virus.But the company's lineup is much bigger than just this one vaccine. Some of Pfizer's top-performing products include anticoagulant Eliquis and cancer treatments Ibrance and Xtandi. Sales of Eliquis for fiscal year 2020 (ended Dec. 31) were $4.9 billion, a 17% year-over-year increase. Ibrance's revenue jumped by 9% year over year to $5.4 billion, while Xtandi's sales came in at roughly $1 billion, representing 22% growth from fiscal year 2019.Pfizer also boasts 95 programs in its pipeline, including 24 ongoing phase 3 studies. Pfizer is well-positioned to keep adding new revenue sources to its lineup every year. Lastly, it is worth noting that Pfizer spun-off its off-patent medicine unit Upjohn to the company formerly known as Mylan. The combined entity of Mylan and Upjohn is called Viatris, and it started trading on the market on Nov. 17.Pfizer decided to make this move because Upjohn's declining sales were hurting its bottom line. The company can now focus on its more profitable biopharma business. This focus should help Pfizer improve its financial results, which will help its stock recover from its underperformance relative to the market in the past year.With a more focused business, a short-term catalyst in the form of its coronavirus vaccine, other medicines with growing sales, and a rich pipeline to keep revenue sources coming, this pharma stock looks like a much better long-term bet than AMC or GameStop.Image source: Getty Images2. NetflixNetflix is already one of the leading streaming video platforms in the world, but the company isn't done growing. What are the opportunities ahead for the tech giant? First, the company is looking to add even more users to its platform. As of its fourth quarter ending Dec. 31, the company had 8.51 million net new subscribers. It ended the period with a total of 203.7 million paid subscriptions, representing a year-over-year increase of 21.9%. Netflix thinks it will add 6 million new subscribers in the first quarter of 2021.And the streaming services industry as a whole has a long runway for growth. According to Grand View Research, this market was worth 50.1 billion in 2020, and it is projected to expand at a compound annual growth rate (CAGR) of 21% between 2021 and 2028.As one of the most recognizable names in this segment, Netflix is well-positioned to profit, especially since competing streaming platforms are more than capable of coexisting. One of the most powerful weapons in these platforms' arsenals is original content, and Netflix has been pouring money into original series and movies in the hopes of building a library people will want to keep coming back to.Image source: Getty Images.These investments have played an important role in the company's success in recent years. Since the content on Netflix is different from that of some of its peers, many customers are more than happy to pay for subscriptions to several companies in this space. The long-term plan for Netflix is simple: Replace regular TV.The company offers several advantages over cable: no ads, no long-term contracts, and on-demand movies and series streaming on any device. And while some cable providers have started to adapt to the new paradigm, Netflix is well on its way to continue its long winning streak in the streaming industry. Those factors make the company's stock worth a buy.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":3811560,"gmtCreate":1615934239683,"gmtModify":1635753515395,"authorId":3572824646640760,"author":{"id":3572824646640760,"authorId":3572824646640760,"name":"Haohao2324","avatar":"https://static.tigerbbs.com/5741ee0bde82c7782d814be80e181a3e","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":325799410,"type":1,"supId":0,"prevId":0,"content":"Like","text":"Like","html":"Like"}],"langContent":"EN"},{"id":325476439,"gmtCreate":1615929972721,"gmtModify":1703495102079,"author":{"id":"3574547862188011","authorId":"3574547862188011","name":"kcwang4982","avatar":"https://static.tigerbbs.com/c04d43cdb908fc01d7c2eb3734205700","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/325476439","repostId":2119619927,"repostType":4,"repost":{"id":"2119619927","pubTimestamp":1615907700,"share":"https://www.laohu8.com/m/news/2119619927?lang=&edition=full","pubTime":"2021-03-16 23:15","market":"us","language":"en","title":"Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys","url":"https://stock-news.laohu8.com/highlight/detail?id=2119619927","media":"Prosper Junior Bakiny","summary":"No need to invest in faltering businesses -- these two winning companies are better bets.","content":"<p>The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the list of the 100 most popular stocks on the platform. However, some of the stocks on that list are head-scratchers. For instance, <b>GameStop</b> (NYSE:GME) and <b>AMC Entertainment</b> (NYSE:AMC) are among the top 20 most commonly held stocks on the app as of this writing.</p><p>Both of these businesses are struggling, in part due to their reliance on brick-and-mortar operations, which were severely impacted by the pandemic. Further, both AMC and Gamestop were at the center of the now (in)famous short-squeeze fiasco orchestrated by traders from Reddit's r/WallStreetBets. Investors would be better off staying away from these two unpredictable companies and instead purchasing shares of Robinhood stocks with solid futures ahead of them. Two such companies worth considering are <b>Pfizer</b> (NYSE:PFE) and <b>Netflix</b> (NASDAQ:NFLX).</p><p><img src=\"https://media.ycharts.com/charts/693c6b3570e5dc157db6f1cb5d80481e.png\" tg-width=\"720\" tg-height=\"387\" referrerpolicy=\"no-referrer\"></p><p>^SPX data by YCharts</p><p><b>1. Pfizer</b></p><p>You've probably heard a lot about Pfizer in the past few months. The company and its partner, <b>BioNTech</b>, developed BNT162b2, and received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) in December, becoming the first authorized COVID-19 vaccine in the U.S. BNT162b2 has also been approved in the European Union.</p><p>While Pfizer and BioNTech have to share the vaccine supply gameboard with several other companies, including <b>Johnson &amp; Johnson</b>, <b>AstraZeneca</b>, and <b>Moderna</b>, the market (i.e., the entire world) is large enough for there to be multiple winners. In other words, BNT162b2 will contribute meaningfully to Pfizer's top line, especially since there is evidence of it being effective against some of the newer variants of the virus.</p><p>But the company's lineup is much bigger than just this <a href=\"https://laohu8.com/S/AONE\">one</a> vaccine. Some of Pfizer's top-performing products include anticoagulant Eliquis and cancer treatments Ibrance and Xtandi. Sales of Eliquis for fiscal year 2020 (ended Dec. 31) were $4.9 billion, a 17% year-over-year increase. Ibrance's revenue jumped by 9% year over year to $5.4 billion, while Xtandi's sales came in at roughly $1 billion, representing 22% growth from fiscal year 2019.</p><p>Pfizer also boasts 95 programs in its pipeline, including 24 ongoing phase 3 studies. Pfizer is well-positioned to keep adding new revenue sources to its lineup every year. Lastly, it is worth noting that Pfizer spun-off its off-patent medicine unit Upjohn to the company formerly known as Mylan. The combined entity of Mylan and Upjohn is called <b>Viatris</b>, and it started trading on the market on Nov. 17.</p><p>Pfizer decided to make this move because Upjohn's declining sales were hurting its bottom line. The company can now focus on its more profitable biopharma business. This focus should help Pfizer improve its financial results, which will help its stock recover from its underperformance relative to the market in the past year.</p><p>With a more focused business, a short-term catalyst in the form of its coronavirus vaccine, other medicines with growing sales, and a rich pipeline to keep revenue sources coming, this pharma stock looks like a much better long-term bet than AMC or GameStop.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F617555%2Fgettyimages-1291715271.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images</p><p><b>2. Netflix</b></p><p>Netflix is already <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leading streaming video platforms in the world, but the company isn't done growing. What are the opportunities ahead for the tech giant? First, the company is looking to add even more users to its platform. As of its fourth quarter ending Dec. 31, the company had 8.51 million net new subscribers. It ended the period with a total of 203.7 million paid subscriptions, representing a year-over-year increase of 21.9%. Netflix thinks it will add 6 million new subscribers in the first quarter of 2021.</p><p>And the streaming services industry as a whole has a long runway for growth. According to Grand View Research, this market was worth 50.1 billion in 2020, and it is projected to expand at a compound annual growth rate (CAGR) of 21% between 2021 and 2028.</p><p>As one of the most recognizable names in this segment, Netflix is well-positioned to profit, especially since competing streaming platforms are more than capable of coexisting. One of the most powerful weapons in these platforms' arsenals is original content, and Netflix has been pouring money into original series and movies in the hopes of building a library people will want to keep coming back to.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F617555%2Fgettyimages-1174414330.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images.</p><p>These investments have played an important role in the company's success in recent years. Since the content on Netflix is different from that of some of its peers,&nbsp;many customers are more than happy to pay for subscriptions to several companies in this space. The long-term plan for Netflix is simple: Replace regular TV.</p><p>The company offers several advantages over cable: no ads, no long-term contracts, and on-demand movies and series streaming on any device. And while some cable providers have started to adapt to the new paradigm, Netflix is well on its way to continue its long winning streak in the streaming industry. Those factors make the company's stock worth a buy.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nForget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-16 23:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/><strong>Prosper Junior Bakiny</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BPOPM":"Popular","BPOPN":"Popular"},"source_url":"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2119619927","content_text":"The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the list of the 100 most popular stocks on the platform. However, some of the stocks on that list are head-scratchers. For instance, GameStop (NYSE:GME) and AMC Entertainment (NYSE:AMC) are among the top 20 most commonly held stocks on the app as of this writing.Both of these businesses are struggling, in part due to their reliance on brick-and-mortar operations, which were severely impacted by the pandemic. Further, both AMC and Gamestop were at the center of the now (in)famous short-squeeze fiasco orchestrated by traders from Reddit's r/WallStreetBets. Investors would be better off staying away from these two unpredictable companies and instead purchasing shares of Robinhood stocks with solid futures ahead of them. Two such companies worth considering are Pfizer (NYSE:PFE) and Netflix (NASDAQ:NFLX).^SPX data by YCharts1. PfizerYou've probably heard a lot about Pfizer in the past few months. The company and its partner, BioNTech, developed BNT162b2, and received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) in December, becoming the first authorized COVID-19 vaccine in the U.S. BNT162b2 has also been approved in the European Union.While Pfizer and BioNTech have to share the vaccine supply gameboard with several other companies, including Johnson & Johnson, AstraZeneca, and Moderna, the market (i.e., the entire world) is large enough for there to be multiple winners. In other words, BNT162b2 will contribute meaningfully to Pfizer's top line, especially since there is evidence of it being effective against some of the newer variants of the virus.But the company's lineup is much bigger than just this one vaccine. Some of Pfizer's top-performing products include anticoagulant Eliquis and cancer treatments Ibrance and Xtandi. Sales of Eliquis for fiscal year 2020 (ended Dec. 31) were $4.9 billion, a 17% year-over-year increase. Ibrance's revenue jumped by 9% year over year to $5.4 billion, while Xtandi's sales came in at roughly $1 billion, representing 22% growth from fiscal year 2019.Pfizer also boasts 95 programs in its pipeline, including 24 ongoing phase 3 studies. Pfizer is well-positioned to keep adding new revenue sources to its lineup every year. Lastly, it is worth noting that Pfizer spun-off its off-patent medicine unit Upjohn to the company formerly known as Mylan. The combined entity of Mylan and Upjohn is called Viatris, and it started trading on the market on Nov. 17.Pfizer decided to make this move because Upjohn's declining sales were hurting its bottom line. The company can now focus on its more profitable biopharma business. This focus should help Pfizer improve its financial results, which will help its stock recover from its underperformance relative to the market in the past year.With a more focused business, a short-term catalyst in the form of its coronavirus vaccine, other medicines with growing sales, and a rich pipeline to keep revenue sources coming, this pharma stock looks like a much better long-term bet than AMC or GameStop.Image source: Getty Images2. NetflixNetflix is already one of the leading streaming video platforms in the world, but the company isn't done growing. What are the opportunities ahead for the tech giant? First, the company is looking to add even more users to its platform. As of its fourth quarter ending Dec. 31, the company had 8.51 million net new subscribers. It ended the period with a total of 203.7 million paid subscriptions, representing a year-over-year increase of 21.9%. Netflix thinks it will add 6 million new subscribers in the first quarter of 2021.And the streaming services industry as a whole has a long runway for growth. According to Grand View Research, this market was worth 50.1 billion in 2020, and it is projected to expand at a compound annual growth rate (CAGR) of 21% between 2021 and 2028.As one of the most recognizable names in this segment, Netflix is well-positioned to profit, especially since competing streaming platforms are more than capable of coexisting. One of the most powerful weapons in these platforms' arsenals is original content, and Netflix has been pouring money into original series and movies in the hopes of building a library people will want to keep coming back to.Image source: Getty Images.These investments have played an important role in the company's success in recent years. Since the content on Netflix is different from that of some of its peers, many customers are more than happy to pay for subscriptions to several companies in this space. The long-term plan for Netflix is simple: Replace regular TV.The company offers several advantages over cable: no ads, no long-term contracts, and on-demand movies and series streaming on any device. And while some cable providers have started to adapt to the new paradigm, Netflix is well on its way to continue its long winning streak in the streaming industry. Those factors make the company's stock worth a buy.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":325445270,"gmtCreate":1615925651490,"gmtModify":1703495090670,"author":{"id":"3568670730120248","authorId":"3568670730120248","name":"Ultrarich","avatar":"https://static.tigerbbs.com/8ce1267f9c547d255e49c7eedc1b3edd","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Robbinthehood? Not sure","listText":"Robbinthehood? Not sure","text":"Robbinthehood? Not sure","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/325445270","repostId":2119619927,"repostType":4,"repost":{"id":"2119619927","pubTimestamp":1615907700,"share":"https://www.laohu8.com/m/news/2119619927?lang=&edition=full","pubTime":"2021-03-16 23:15","market":"us","language":"en","title":"Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys","url":"https://stock-news.laohu8.com/highlight/detail?id=2119619927","media":"Prosper Junior Bakiny","summary":"No need to invest in faltering businesses -- these two winning companies are better bets.","content":"<p>The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the list of the 100 most popular stocks on the platform. However, some of the stocks on that list are head-scratchers. For instance, <b>GameStop</b> (NYSE:GME) and <b>AMC Entertainment</b> (NYSE:AMC) are among the top 20 most commonly held stocks on the app as of this writing.</p><p>Both of these businesses are struggling, in part due to their reliance on brick-and-mortar operations, which were severely impacted by the pandemic. Further, both AMC and Gamestop were at the center of the now (in)famous short-squeeze fiasco orchestrated by traders from Reddit's r/WallStreetBets. Investors would be better off staying away from these two unpredictable companies and instead purchasing shares of Robinhood stocks with solid futures ahead of them. Two such companies worth considering are <b>Pfizer</b> (NYSE:PFE) and <b>Netflix</b> (NASDAQ:NFLX).</p><p><img src=\"https://media.ycharts.com/charts/693c6b3570e5dc157db6f1cb5d80481e.png\" tg-width=\"720\" tg-height=\"387\" referrerpolicy=\"no-referrer\"></p><p>^SPX data by YCharts</p><p><b>1. Pfizer</b></p><p>You've probably heard a lot about Pfizer in the past few months. The company and its partner, <b>BioNTech</b>, developed BNT162b2, and received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) in December, becoming the first authorized COVID-19 vaccine in the U.S. BNT162b2 has also been approved in the European Union.</p><p>While Pfizer and BioNTech have to share the vaccine supply gameboard with several other companies, including <b>Johnson &amp; Johnson</b>, <b>AstraZeneca</b>, and <b>Moderna</b>, the market (i.e., the entire world) is large enough for there to be multiple winners. In other words, BNT162b2 will contribute meaningfully to Pfizer's top line, especially since there is evidence of it being effective against some of the newer variants of the virus.</p><p>But the company's lineup is much bigger than just this <a href=\"https://laohu8.com/S/AONE\">one</a> vaccine. Some of Pfizer's top-performing products include anticoagulant Eliquis and cancer treatments Ibrance and Xtandi. Sales of Eliquis for fiscal year 2020 (ended Dec. 31) were $4.9 billion, a 17% year-over-year increase. Ibrance's revenue jumped by 9% year over year to $5.4 billion, while Xtandi's sales came in at roughly $1 billion, representing 22% growth from fiscal year 2019.</p><p>Pfizer also boasts 95 programs in its pipeline, including 24 ongoing phase 3 studies. Pfizer is well-positioned to keep adding new revenue sources to its lineup every year. Lastly, it is worth noting that Pfizer spun-off its off-patent medicine unit Upjohn to the company formerly known as Mylan. The combined entity of Mylan and Upjohn is called <b>Viatris</b>, and it started trading on the market on Nov. 17.</p><p>Pfizer decided to make this move because Upjohn's declining sales were hurting its bottom line. The company can now focus on its more profitable biopharma business. This focus should help Pfizer improve its financial results, which will help its stock recover from its underperformance relative to the market in the past year.</p><p>With a more focused business, a short-term catalyst in the form of its coronavirus vaccine, other medicines with growing sales, and a rich pipeline to keep revenue sources coming, this pharma stock looks like a much better long-term bet than AMC or GameStop.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F617555%2Fgettyimages-1291715271.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images</p><p><b>2. Netflix</b></p><p>Netflix is already <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leading streaming video platforms in the world, but the company isn't done growing. What are the opportunities ahead for the tech giant? First, the company is looking to add even more users to its platform. As of its fourth quarter ending Dec. 31, the company had 8.51 million net new subscribers. It ended the period with a total of 203.7 million paid subscriptions, representing a year-over-year increase of 21.9%. Netflix thinks it will add 6 million new subscribers in the first quarter of 2021.</p><p>And the streaming services industry as a whole has a long runway for growth. According to Grand View Research, this market was worth 50.1 billion in 2020, and it is projected to expand at a compound annual growth rate (CAGR) of 21% between 2021 and 2028.</p><p>As one of the most recognizable names in this segment, Netflix is well-positioned to profit, especially since competing streaming platforms are more than capable of coexisting. One of the most powerful weapons in these platforms' arsenals is original content, and Netflix has been pouring money into original series and movies in the hopes of building a library people will want to keep coming back to.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F617555%2Fgettyimages-1174414330.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images.</p><p>These investments have played an important role in the company's success in recent years. Since the content on Netflix is different from that of some of its peers,&nbsp;many customers are more than happy to pay for subscriptions to several companies in this space. The long-term plan for Netflix is simple: Replace regular TV.</p><p>The company offers several advantages over cable: no ads, no long-term contracts, and on-demand movies and series streaming on any device. And while some cable providers have started to adapt to the new paradigm, Netflix is well on its way to continue its long winning streak in the streaming industry. Those factors make the company's stock worth a buy.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nForget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-16 23:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/><strong>Prosper Junior Bakiny</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BPOPM":"Popular","BPOPN":"Popular"},"source_url":"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2119619927","content_text":"The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the list of the 100 most popular stocks on the platform. However, some of the stocks on that list are head-scratchers. For instance, GameStop (NYSE:GME) and AMC Entertainment (NYSE:AMC) are among the top 20 most commonly held stocks on the app as of this writing.Both of these businesses are struggling, in part due to their reliance on brick-and-mortar operations, which were severely impacted by the pandemic. Further, both AMC and Gamestop were at the center of the now (in)famous short-squeeze fiasco orchestrated by traders from Reddit's r/WallStreetBets. Investors would be better off staying away from these two unpredictable companies and instead purchasing shares of Robinhood stocks with solid futures ahead of them. Two such companies worth considering are Pfizer (NYSE:PFE) and Netflix (NASDAQ:NFLX).^SPX data by YCharts1. PfizerYou've probably heard a lot about Pfizer in the past few months. The company and its partner, BioNTech, developed BNT162b2, and received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) in December, becoming the first authorized COVID-19 vaccine in the U.S. BNT162b2 has also been approved in the European Union.While Pfizer and BioNTech have to share the vaccine supply gameboard with several other companies, including Johnson & Johnson, AstraZeneca, and Moderna, the market (i.e., the entire world) is large enough for there to be multiple winners. In other words, BNT162b2 will contribute meaningfully to Pfizer's top line, especially since there is evidence of it being effective against some of the newer variants of the virus.But the company's lineup is much bigger than just this one vaccine. Some of Pfizer's top-performing products include anticoagulant Eliquis and cancer treatments Ibrance and Xtandi. Sales of Eliquis for fiscal year 2020 (ended Dec. 31) were $4.9 billion, a 17% year-over-year increase. Ibrance's revenue jumped by 9% year over year to $5.4 billion, while Xtandi's sales came in at roughly $1 billion, representing 22% growth from fiscal year 2019.Pfizer also boasts 95 programs in its pipeline, including 24 ongoing phase 3 studies. Pfizer is well-positioned to keep adding new revenue sources to its lineup every year. Lastly, it is worth noting that Pfizer spun-off its off-patent medicine unit Upjohn to the company formerly known as Mylan. The combined entity of Mylan and Upjohn is called Viatris, and it started trading on the market on Nov. 17.Pfizer decided to make this move because Upjohn's declining sales were hurting its bottom line. The company can now focus on its more profitable biopharma business. This focus should help Pfizer improve its financial results, which will help its stock recover from its underperformance relative to the market in the past year.With a more focused business, a short-term catalyst in the form of its coronavirus vaccine, other medicines with growing sales, and a rich pipeline to keep revenue sources coming, this pharma stock looks like a much better long-term bet than AMC or GameStop.Image source: Getty Images2. NetflixNetflix is already one of the leading streaming video platforms in the world, but the company isn't done growing. What are the opportunities ahead for the tech giant? First, the company is looking to add even more users to its platform. As of its fourth quarter ending Dec. 31, the company had 8.51 million net new subscribers. It ended the period with a total of 203.7 million paid subscriptions, representing a year-over-year increase of 21.9%. Netflix thinks it will add 6 million new subscribers in the first quarter of 2021.And the streaming services industry as a whole has a long runway for growth. According to Grand View Research, this market was worth 50.1 billion in 2020, and it is projected to expand at a compound annual growth rate (CAGR) of 21% between 2021 and 2028.As one of the most recognizable names in this segment, Netflix is well-positioned to profit, especially since competing streaming platforms are more than capable of coexisting. One of the most powerful weapons in these platforms' arsenals is original content, and Netflix has been pouring money into original series and movies in the hopes of building a library people will want to keep coming back to.Image source: Getty Images.These investments have played an important role in the company's success in recent years. Since the content on Netflix is different from that of some of its peers, many customers are more than happy to pay for subscriptions to several companies in this space. The long-term plan for Netflix is simple: Replace regular TV.The company offers several advantages over cable: no ads, no long-term contracts, and on-demand movies and series streaming on any device. And while some cable providers have started to adapt to the new paradigm, Netflix is well on its way to continue its long winning streak in the streaming industry. Those factors make the company's stock worth a buy.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":325440793,"gmtCreate":1615922396112,"gmtModify":1703495081296,"author":{"id":"3574953476578972","authorId":"3574953476578972","name":"Rorym","avatar":"https://static.tigerbbs.com/0dda81f63d9974f7e5a012ec12f3b6d9","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Wow really good read&nbsp;","listText":"Wow really good read&nbsp;","text":"Wow really good read","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/325440793","repostId":2119619927,"repostType":4,"repost":{"id":"2119619927","pubTimestamp":1615907700,"share":"https://www.laohu8.com/m/news/2119619927?lang=&edition=full","pubTime":"2021-03-16 23:15","market":"us","language":"en","title":"Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys","url":"https://stock-news.laohu8.com/highlight/detail?id=2119619927","media":"Prosper Junior Bakiny","summary":"No need to invest in faltering businesses -- these two winning companies are better bets.","content":"<p>The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the list of the 100 most popular stocks on the platform. However, some of the stocks on that list are head-scratchers. For instance, <b>GameStop</b> (NYSE:GME) and <b>AMC Entertainment</b> (NYSE:AMC) are among the top 20 most commonly held stocks on the app as of this writing.</p><p>Both of these businesses are struggling, in part due to their reliance on brick-and-mortar operations, which were severely impacted by the pandemic. Further, both AMC and Gamestop were at the center of the now (in)famous short-squeeze fiasco orchestrated by traders from Reddit's r/WallStreetBets. Investors would be better off staying away from these two unpredictable companies and instead purchasing shares of Robinhood stocks with solid futures ahead of them. Two such companies worth considering are <b>Pfizer</b> (NYSE:PFE) and <b>Netflix</b> (NASDAQ:NFLX).</p><p><img src=\"https://media.ycharts.com/charts/693c6b3570e5dc157db6f1cb5d80481e.png\" tg-width=\"720\" tg-height=\"387\" referrerpolicy=\"no-referrer\"></p><p>^SPX data by YCharts</p><p><b>1. Pfizer</b></p><p>You've probably heard a lot about Pfizer in the past few months. The company and its partner, <b>BioNTech</b>, developed BNT162b2, and received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) in December, becoming the first authorized COVID-19 vaccine in the U.S. BNT162b2 has also been approved in the European Union.</p><p>While Pfizer and BioNTech have to share the vaccine supply gameboard with several other companies, including <b>Johnson &amp; Johnson</b>, <b>AstraZeneca</b>, and <b>Moderna</b>, the market (i.e., the entire world) is large enough for there to be multiple winners. In other words, BNT162b2 will contribute meaningfully to Pfizer's top line, especially since there is evidence of it being effective against some of the newer variants of the virus.</p><p>But the company's lineup is much bigger than just this <a href=\"https://laohu8.com/S/AONE\">one</a> vaccine. Some of Pfizer's top-performing products include anticoagulant Eliquis and cancer treatments Ibrance and Xtandi. Sales of Eliquis for fiscal year 2020 (ended Dec. 31) were $4.9 billion, a 17% year-over-year increase. Ibrance's revenue jumped by 9% year over year to $5.4 billion, while Xtandi's sales came in at roughly $1 billion, representing 22% growth from fiscal year 2019.</p><p>Pfizer also boasts 95 programs in its pipeline, including 24 ongoing phase 3 studies. Pfizer is well-positioned to keep adding new revenue sources to its lineup every year. Lastly, it is worth noting that Pfizer spun-off its off-patent medicine unit Upjohn to the company formerly known as Mylan. The combined entity of Mylan and Upjohn is called <b>Viatris</b>, and it started trading on the market on Nov. 17.</p><p>Pfizer decided to make this move because Upjohn's declining sales were hurting its bottom line. The company can now focus on its more profitable biopharma business. This focus should help Pfizer improve its financial results, which will help its stock recover from its underperformance relative to the market in the past year.</p><p>With a more focused business, a short-term catalyst in the form of its coronavirus vaccine, other medicines with growing sales, and a rich pipeline to keep revenue sources coming, this pharma stock looks like a much better long-term bet than AMC or GameStop.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F617555%2Fgettyimages-1291715271.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images</p><p><b>2. Netflix</b></p><p>Netflix is already <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leading streaming video platforms in the world, but the company isn't done growing. What are the opportunities ahead for the tech giant? First, the company is looking to add even more users to its platform. As of its fourth quarter ending Dec. 31, the company had 8.51 million net new subscribers. It ended the period with a total of 203.7 million paid subscriptions, representing a year-over-year increase of 21.9%. Netflix thinks it will add 6 million new subscribers in the first quarter of 2021.</p><p>And the streaming services industry as a whole has a long runway for growth. According to Grand View Research, this market was worth 50.1 billion in 2020, and it is projected to expand at a compound annual growth rate (CAGR) of 21% between 2021 and 2028.</p><p>As one of the most recognizable names in this segment, Netflix is well-positioned to profit, especially since competing streaming platforms are more than capable of coexisting. One of the most powerful weapons in these platforms' arsenals is original content, and Netflix has been pouring money into original series and movies in the hopes of building a library people will want to keep coming back to.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F617555%2Fgettyimages-1174414330.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images.</p><p>These investments have played an important role in the company's success in recent years. Since the content on Netflix is different from that of some of its peers,&nbsp;many customers are more than happy to pay for subscriptions to several companies in this space. The long-term plan for Netflix is simple: Replace regular TV.</p><p>The company offers several advantages over cable: no ads, no long-term contracts, and on-demand movies and series streaming on any device. And while some cable providers have started to adapt to the new paradigm, Netflix is well on its way to continue its long winning streak in the streaming industry. Those factors make the company's stock worth a buy.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nForget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-16 23:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/><strong>Prosper Junior Bakiny</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BPOPM":"Popular","BPOPN":"Popular"},"source_url":"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2119619927","content_text":"The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the list of the 100 most popular stocks on the platform. However, some of the stocks on that list are head-scratchers. For instance, GameStop (NYSE:GME) and AMC Entertainment (NYSE:AMC) are among the top 20 most commonly held stocks on the app as of this writing.Both of these businesses are struggling, in part due to their reliance on brick-and-mortar operations, which were severely impacted by the pandemic. Further, both AMC and Gamestop were at the center of the now (in)famous short-squeeze fiasco orchestrated by traders from Reddit's r/WallStreetBets. Investors would be better off staying away from these two unpredictable companies and instead purchasing shares of Robinhood stocks with solid futures ahead of them. Two such companies worth considering are Pfizer (NYSE:PFE) and Netflix (NASDAQ:NFLX).^SPX data by YCharts1. PfizerYou've probably heard a lot about Pfizer in the past few months. The company and its partner, BioNTech, developed BNT162b2, and received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) in December, becoming the first authorized COVID-19 vaccine in the U.S. BNT162b2 has also been approved in the European Union.While Pfizer and BioNTech have to share the vaccine supply gameboard with several other companies, including Johnson & Johnson, AstraZeneca, and Moderna, the market (i.e., the entire world) is large enough for there to be multiple winners. In other words, BNT162b2 will contribute meaningfully to Pfizer's top line, especially since there is evidence of it being effective against some of the newer variants of the virus.But the company's lineup is much bigger than just this one vaccine. Some of Pfizer's top-performing products include anticoagulant Eliquis and cancer treatments Ibrance and Xtandi. Sales of Eliquis for fiscal year 2020 (ended Dec. 31) were $4.9 billion, a 17% year-over-year increase. Ibrance's revenue jumped by 9% year over year to $5.4 billion, while Xtandi's sales came in at roughly $1 billion, representing 22% growth from fiscal year 2019.Pfizer also boasts 95 programs in its pipeline, including 24 ongoing phase 3 studies. Pfizer is well-positioned to keep adding new revenue sources to its lineup every year. Lastly, it is worth noting that Pfizer spun-off its off-patent medicine unit Upjohn to the company formerly known as Mylan. The combined entity of Mylan and Upjohn is called Viatris, and it started trading on the market on Nov. 17.Pfizer decided to make this move because Upjohn's declining sales were hurting its bottom line. The company can now focus on its more profitable biopharma business. This focus should help Pfizer improve its financial results, which will help its stock recover from its underperformance relative to the market in the past year.With a more focused business, a short-term catalyst in the form of its coronavirus vaccine, other medicines with growing sales, and a rich pipeline to keep revenue sources coming, this pharma stock looks like a much better long-term bet than AMC or GameStop.Image source: Getty Images2. NetflixNetflix is already one of the leading streaming video platforms in the world, but the company isn't done growing. What are the opportunities ahead for the tech giant? First, the company is looking to add even more users to its platform. As of its fourth quarter ending Dec. 31, the company had 8.51 million net new subscribers. It ended the period with a total of 203.7 million paid subscriptions, representing a year-over-year increase of 21.9%. Netflix thinks it will add 6 million new subscribers in the first quarter of 2021.And the streaming services industry as a whole has a long runway for growth. According to Grand View Research, this market was worth 50.1 billion in 2020, and it is projected to expand at a compound annual growth rate (CAGR) of 21% between 2021 and 2028.As one of the most recognizable names in this segment, Netflix is well-positioned to profit, especially since competing streaming platforms are more than capable of coexisting. One of the most powerful weapons in these platforms' arsenals is original content, and Netflix has been pouring money into original series and movies in the hopes of building a library people will want to keep coming back to.Image source: Getty Images.These investments have played an important role in the company's success in recent years. Since the content on Netflix is different from that of some of its peers, many customers are more than happy to pay for subscriptions to several companies in this space. The long-term plan for Netflix is simple: Replace regular TV.The company offers several advantages over cable: no ads, no long-term contracts, and on-demand movies and series streaming on any device. And while some cable providers have started to adapt to the new paradigm, Netflix is well on its way to continue its long winning streak in the streaming industry. Those factors make the company's stock worth a buy.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":325488040,"gmtCreate":1615913140280,"gmtModify":1703495033818,"author":{"id":"3577214154165799","authorId":"3577214154165799","name":"Erat","avatar":"https://static.tigerbbs.com/15f49099eac161060ea690bf80ddf281","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Hmm","listText":"Hmm","text":"Hmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/325488040","repostId":2119619927,"repostType":4,"repost":{"id":"2119619927","pubTimestamp":1615907700,"share":"https://www.laohu8.com/m/news/2119619927?lang=&edition=full","pubTime":"2021-03-16 23:15","market":"us","language":"en","title":"Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys","url":"https://stock-news.laohu8.com/highlight/detail?id=2119619927","media":"Prosper Junior Bakiny","summary":"No need to invest in faltering businesses -- these two winning companies are better bets.","content":"<p>The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the list of the 100 most popular stocks on the platform. However, some of the stocks on that list are head-scratchers. For instance, <b>GameStop</b> (NYSE:GME) and <b>AMC Entertainment</b> (NYSE:AMC) are among the top 20 most commonly held stocks on the app as of this writing.</p><p>Both of these businesses are struggling, in part due to their reliance on brick-and-mortar operations, which were severely impacted by the pandemic. Further, both AMC and Gamestop were at the center of the now (in)famous short-squeeze fiasco orchestrated by traders from Reddit's r/WallStreetBets. Investors would be better off staying away from these two unpredictable companies and instead purchasing shares of Robinhood stocks with solid futures ahead of them. Two such companies worth considering are <b>Pfizer</b> (NYSE:PFE) and <b>Netflix</b> (NASDAQ:NFLX).</p><p><img src=\"https://media.ycharts.com/charts/693c6b3570e5dc157db6f1cb5d80481e.png\" tg-width=\"720\" tg-height=\"387\" referrerpolicy=\"no-referrer\"></p><p>^SPX data by YCharts</p><p><b>1. Pfizer</b></p><p>You've probably heard a lot about Pfizer in the past few months. The company and its partner, <b>BioNTech</b>, developed BNT162b2, and received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) in December, becoming the first authorized COVID-19 vaccine in the U.S. BNT162b2 has also been approved in the European Union.</p><p>While Pfizer and BioNTech have to share the vaccine supply gameboard with several other companies, including <b>Johnson &amp; Johnson</b>, <b>AstraZeneca</b>, and <b>Moderna</b>, the market (i.e., the entire world) is large enough for there to be multiple winners. In other words, BNT162b2 will contribute meaningfully to Pfizer's top line, especially since there is evidence of it being effective against some of the newer variants of the virus.</p><p>But the company's lineup is much bigger than just this <a href=\"https://laohu8.com/S/AONE\">one</a> vaccine. Some of Pfizer's top-performing products include anticoagulant Eliquis and cancer treatments Ibrance and Xtandi. Sales of Eliquis for fiscal year 2020 (ended Dec. 31) were $4.9 billion, a 17% year-over-year increase. Ibrance's revenue jumped by 9% year over year to $5.4 billion, while Xtandi's sales came in at roughly $1 billion, representing 22% growth from fiscal year 2019.</p><p>Pfizer also boasts 95 programs in its pipeline, including 24 ongoing phase 3 studies. Pfizer is well-positioned to keep adding new revenue sources to its lineup every year. Lastly, it is worth noting that Pfizer spun-off its off-patent medicine unit Upjohn to the company formerly known as Mylan. The combined entity of Mylan and Upjohn is called <b>Viatris</b>, and it started trading on the market on Nov. 17.</p><p>Pfizer decided to make this move because Upjohn's declining sales were hurting its bottom line. The company can now focus on its more profitable biopharma business. This focus should help Pfizer improve its financial results, which will help its stock recover from its underperformance relative to the market in the past year.</p><p>With a more focused business, a short-term catalyst in the form of its coronavirus vaccine, other medicines with growing sales, and a rich pipeline to keep revenue sources coming, this pharma stock looks like a much better long-term bet than AMC or GameStop.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F617555%2Fgettyimages-1291715271.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images</p><p><b>2. Netflix</b></p><p>Netflix is already <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leading streaming video platforms in the world, but the company isn't done growing. What are the opportunities ahead for the tech giant? First, the company is looking to add even more users to its platform. As of its fourth quarter ending Dec. 31, the company had 8.51 million net new subscribers. It ended the period with a total of 203.7 million paid subscriptions, representing a year-over-year increase of 21.9%. Netflix thinks it will add 6 million new subscribers in the first quarter of 2021.</p><p>And the streaming services industry as a whole has a long runway for growth. According to Grand View Research, this market was worth 50.1 billion in 2020, and it is projected to expand at a compound annual growth rate (CAGR) of 21% between 2021 and 2028.</p><p>As one of the most recognizable names in this segment, Netflix is well-positioned to profit, especially since competing streaming platforms are more than capable of coexisting. One of the most powerful weapons in these platforms' arsenals is original content, and Netflix has been pouring money into original series and movies in the hopes of building a library people will want to keep coming back to.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F617555%2Fgettyimages-1174414330.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images.</p><p>These investments have played an important role in the company's success in recent years. Since the content on Netflix is different from that of some of its peers,&nbsp;many customers are more than happy to pay for subscriptions to several companies in this space. The long-term plan for Netflix is simple: Replace regular TV.</p><p>The company offers several advantages over cable: no ads, no long-term contracts, and on-demand movies and series streaming on any device. And while some cable providers have started to adapt to the new paradigm, Netflix is well on its way to continue its long winning streak in the streaming industry. Those factors make the company's stock worth a buy.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nForget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-16 23:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/><strong>Prosper Junior Bakiny</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BPOPM":"Popular","BPOPN":"Popular"},"source_url":"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2119619927","content_text":"The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the list of the 100 most popular stocks on the platform. However, some of the stocks on that list are head-scratchers. For instance, GameStop (NYSE:GME) and AMC Entertainment (NYSE:AMC) are among the top 20 most commonly held stocks on the app as of this writing.Both of these businesses are struggling, in part due to their reliance on brick-and-mortar operations, which were severely impacted by the pandemic. Further, both AMC and Gamestop were at the center of the now (in)famous short-squeeze fiasco orchestrated by traders from Reddit's r/WallStreetBets. Investors would be better off staying away from these two unpredictable companies and instead purchasing shares of Robinhood stocks with solid futures ahead of them. Two such companies worth considering are Pfizer (NYSE:PFE) and Netflix (NASDAQ:NFLX).^SPX data by YCharts1. PfizerYou've probably heard a lot about Pfizer in the past few months. The company and its partner, BioNTech, developed BNT162b2, and received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) in December, becoming the first authorized COVID-19 vaccine in the U.S. BNT162b2 has also been approved in the European Union.While Pfizer and BioNTech have to share the vaccine supply gameboard with several other companies, including Johnson & Johnson, AstraZeneca, and Moderna, the market (i.e., the entire world) is large enough for there to be multiple winners. In other words, BNT162b2 will contribute meaningfully to Pfizer's top line, especially since there is evidence of it being effective against some of the newer variants of the virus.But the company's lineup is much bigger than just this one vaccine. Some of Pfizer's top-performing products include anticoagulant Eliquis and cancer treatments Ibrance and Xtandi. Sales of Eliquis for fiscal year 2020 (ended Dec. 31) were $4.9 billion, a 17% year-over-year increase. Ibrance's revenue jumped by 9% year over year to $5.4 billion, while Xtandi's sales came in at roughly $1 billion, representing 22% growth from fiscal year 2019.Pfizer also boasts 95 programs in its pipeline, including 24 ongoing phase 3 studies. Pfizer is well-positioned to keep adding new revenue sources to its lineup every year. Lastly, it is worth noting that Pfizer spun-off its off-patent medicine unit Upjohn to the company formerly known as Mylan. The combined entity of Mylan and Upjohn is called Viatris, and it started trading on the market on Nov. 17.Pfizer decided to make this move because Upjohn's declining sales were hurting its bottom line. The company can now focus on its more profitable biopharma business. This focus should help Pfizer improve its financial results, which will help its stock recover from its underperformance relative to the market in the past year.With a more focused business, a short-term catalyst in the form of its coronavirus vaccine, other medicines with growing sales, and a rich pipeline to keep revenue sources coming, this pharma stock looks like a much better long-term bet than AMC or GameStop.Image source: Getty Images2. NetflixNetflix is already one of the leading streaming video platforms in the world, but the company isn't done growing. What are the opportunities ahead for the tech giant? First, the company is looking to add even more users to its platform. As of its fourth quarter ending Dec. 31, the company had 8.51 million net new subscribers. It ended the period with a total of 203.7 million paid subscriptions, representing a year-over-year increase of 21.9%. Netflix thinks it will add 6 million new subscribers in the first quarter of 2021.And the streaming services industry as a whole has a long runway for growth. According to Grand View Research, this market was worth 50.1 billion in 2020, and it is projected to expand at a compound annual growth rate (CAGR) of 21% between 2021 and 2028.As one of the most recognizable names in this segment, Netflix is well-positioned to profit, especially since competing streaming platforms are more than capable of coexisting. One of the most powerful weapons in these platforms' arsenals is original content, and Netflix has been pouring money into original series and movies in the hopes of building a library people will want to keep coming back to.Image source: Getty Images.These investments have played an important role in the company's success in recent years. Since the content on Netflix is different from that of some of its peers, many customers are more than happy to pay for subscriptions to several companies in this space. The long-term plan for Netflix is simple: Replace regular TV.The company offers several advantages over cable: no ads, no long-term contracts, and on-demand movies and series streaming on any device. And while some cable providers have started to adapt to the new paradigm, Netflix is well on its way to continue its long winning streak in the streaming industry. Those factors make the company's stock worth a buy.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":325495841,"gmtCreate":1615910628283,"gmtModify":1703494992991,"author":{"id":"3574925827192931","authorId":"3574925827192931","name":"JoshyQ","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":8,"crmLevelSwitch":0},"htmlText":"Cool cool cool&nbsp;","listText":"Cool cool cool&nbsp;","text":"Cool cool cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/325495841","repostId":2119619927,"repostType":4,"repost":{"id":"2119619927","pubTimestamp":1615907700,"share":"https://www.laohu8.com/m/news/2119619927?lang=&edition=full","pubTime":"2021-03-16 23:15","market":"us","language":"en","title":"Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys","url":"https://stock-news.laohu8.com/highlight/detail?id=2119619927","media":"Prosper Junior Bakiny","summary":"No need to invest in faltering businesses -- these two winning companies are better bets.","content":"<p>The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the list of the 100 most popular stocks on the platform. However, some of the stocks on that list are head-scratchers. For instance, <b>GameStop</b> (NYSE:GME) and <b>AMC Entertainment</b> (NYSE:AMC) are among the top 20 most commonly held stocks on the app as of this writing.</p><p>Both of these businesses are struggling, in part due to their reliance on brick-and-mortar operations, which were severely impacted by the pandemic. Further, both AMC and Gamestop were at the center of the now (in)famous short-squeeze fiasco orchestrated by traders from Reddit's r/WallStreetBets. Investors would be better off staying away from these two unpredictable companies and instead purchasing shares of Robinhood stocks with solid futures ahead of them. Two such companies worth considering are <b>Pfizer</b> (NYSE:PFE) and <b>Netflix</b> (NASDAQ:NFLX).</p><p><img src=\"https://media.ycharts.com/charts/693c6b3570e5dc157db6f1cb5d80481e.png\" tg-width=\"720\" tg-height=\"387\" referrerpolicy=\"no-referrer\"></p><p>^SPX data by YCharts</p><p><b>1. Pfizer</b></p><p>You've probably heard a lot about Pfizer in the past few months. The company and its partner, <b>BioNTech</b>, developed BNT162b2, and received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) in December, becoming the first authorized COVID-19 vaccine in the U.S. BNT162b2 has also been approved in the European Union.</p><p>While Pfizer and BioNTech have to share the vaccine supply gameboard with several other companies, including <b>Johnson &amp; Johnson</b>, <b>AstraZeneca</b>, and <b>Moderna</b>, the market (i.e., the entire world) is large enough for there to be multiple winners. In other words, BNT162b2 will contribute meaningfully to Pfizer's top line, especially since there is evidence of it being effective against some of the newer variants of the virus.</p><p>But the company's lineup is much bigger than just this <a href=\"https://laohu8.com/S/AONE\">one</a> vaccine. Some of Pfizer's top-performing products include anticoagulant Eliquis and cancer treatments Ibrance and Xtandi. Sales of Eliquis for fiscal year 2020 (ended Dec. 31) were $4.9 billion, a 17% year-over-year increase. Ibrance's revenue jumped by 9% year over year to $5.4 billion, while Xtandi's sales came in at roughly $1 billion, representing 22% growth from fiscal year 2019.</p><p>Pfizer also boasts 95 programs in its pipeline, including 24 ongoing phase 3 studies. Pfizer is well-positioned to keep adding new revenue sources to its lineup every year. Lastly, it is worth noting that Pfizer spun-off its off-patent medicine unit Upjohn to the company formerly known as Mylan. The combined entity of Mylan and Upjohn is called <b>Viatris</b>, and it started trading on the market on Nov. 17.</p><p>Pfizer decided to make this move because Upjohn's declining sales were hurting its bottom line. The company can now focus on its more profitable biopharma business. This focus should help Pfizer improve its financial results, which will help its stock recover from its underperformance relative to the market in the past year.</p><p>With a more focused business, a short-term catalyst in the form of its coronavirus vaccine, other medicines with growing sales, and a rich pipeline to keep revenue sources coming, this pharma stock looks like a much better long-term bet than AMC or GameStop.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F617555%2Fgettyimages-1291715271.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images</p><p><b>2. Netflix</b></p><p>Netflix is already <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the leading streaming video platforms in the world, but the company isn't done growing. What are the opportunities ahead for the tech giant? First, the company is looking to add even more users to its platform. As of its fourth quarter ending Dec. 31, the company had 8.51 million net new subscribers. It ended the period with a total of 203.7 million paid subscriptions, representing a year-over-year increase of 21.9%. Netflix thinks it will add 6 million new subscribers in the first quarter of 2021.</p><p>And the streaming services industry as a whole has a long runway for growth. According to Grand View Research, this market was worth 50.1 billion in 2020, and it is projected to expand at a compound annual growth rate (CAGR) of 21% between 2021 and 2028.</p><p>As one of the most recognizable names in this segment, Netflix is well-positioned to profit, especially since competing streaming platforms are more than capable of coexisting. One of the most powerful weapons in these platforms' arsenals is original content, and Netflix has been pouring money into original series and movies in the hopes of building a library people will want to keep coming back to.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F617555%2Fgettyimages-1174414330.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images.</p><p>These investments have played an important role in the company's success in recent years. Since the content on Netflix is different from that of some of its peers,&nbsp;many customers are more than happy to pay for subscriptions to several companies in this space. The long-term plan for Netflix is simple: Replace regular TV.</p><p>The company offers several advantages over cable: no ads, no long-term contracts, and on-demand movies and series streaming on any device. And while some cable providers have started to adapt to the new paradigm, Netflix is well on its way to continue its long winning streak in the streaming industry. Those factors make the company's stock worth a buy.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nForget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-16 23:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/><strong>Prosper Junior Bakiny</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BPOPM":"Popular","BPOPN":"Popular"},"source_url":"https://www.fool.com/investing/2021/03/16/forget-amc-and-gamestop-2-popular-robinhood-stocks/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2119619927","content_text":"The commission-free trading platform Robinhood is popular among novice investors, millennials, and traders. These groups of market enthusiasts can certainly pick excellent stocks, as evidenced by the list of the 100 most popular stocks on the platform. However, some of the stocks on that list are head-scratchers. For instance, GameStop (NYSE:GME) and AMC Entertainment (NYSE:AMC) are among the top 20 most commonly held stocks on the app as of this writing.Both of these businesses are struggling, in part due to their reliance on brick-and-mortar operations, which were severely impacted by the pandemic. Further, both AMC and Gamestop were at the center of the now (in)famous short-squeeze fiasco orchestrated by traders from Reddit's r/WallStreetBets. Investors would be better off staying away from these two unpredictable companies and instead purchasing shares of Robinhood stocks with solid futures ahead of them. Two such companies worth considering are Pfizer (NYSE:PFE) and Netflix (NASDAQ:NFLX).^SPX data by YCharts1. PfizerYou've probably heard a lot about Pfizer in the past few months. The company and its partner, BioNTech, developed BNT162b2, and received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) in December, becoming the first authorized COVID-19 vaccine in the U.S. BNT162b2 has also been approved in the European Union.While Pfizer and BioNTech have to share the vaccine supply gameboard with several other companies, including Johnson & Johnson, AstraZeneca, and Moderna, the market (i.e., the entire world) is large enough for there to be multiple winners. In other words, BNT162b2 will contribute meaningfully to Pfizer's top line, especially since there is evidence of it being effective against some of the newer variants of the virus.But the company's lineup is much bigger than just this one vaccine. Some of Pfizer's top-performing products include anticoagulant Eliquis and cancer treatments Ibrance and Xtandi. Sales of Eliquis for fiscal year 2020 (ended Dec. 31) were $4.9 billion, a 17% year-over-year increase. Ibrance's revenue jumped by 9% year over year to $5.4 billion, while Xtandi's sales came in at roughly $1 billion, representing 22% growth from fiscal year 2019.Pfizer also boasts 95 programs in its pipeline, including 24 ongoing phase 3 studies. Pfizer is well-positioned to keep adding new revenue sources to its lineup every year. Lastly, it is worth noting that Pfizer spun-off its off-patent medicine unit Upjohn to the company formerly known as Mylan. The combined entity of Mylan and Upjohn is called Viatris, and it started trading on the market on Nov. 17.Pfizer decided to make this move because Upjohn's declining sales were hurting its bottom line. The company can now focus on its more profitable biopharma business. This focus should help Pfizer improve its financial results, which will help its stock recover from its underperformance relative to the market in the past year.With a more focused business, a short-term catalyst in the form of its coronavirus vaccine, other medicines with growing sales, and a rich pipeline to keep revenue sources coming, this pharma stock looks like a much better long-term bet than AMC or GameStop.Image source: Getty Images2. NetflixNetflix is already one of the leading streaming video platforms in the world, but the company isn't done growing. What are the opportunities ahead for the tech giant? First, the company is looking to add even more users to its platform. As of its fourth quarter ending Dec. 31, the company had 8.51 million net new subscribers. It ended the period with a total of 203.7 million paid subscriptions, representing a year-over-year increase of 21.9%. Netflix thinks it will add 6 million new subscribers in the first quarter of 2021.And the streaming services industry as a whole has a long runway for growth. According to Grand View Research, this market was worth 50.1 billion in 2020, and it is projected to expand at a compound annual growth rate (CAGR) of 21% between 2021 and 2028.As one of the most recognizable names in this segment, Netflix is well-positioned to profit, especially since competing streaming platforms are more than capable of coexisting. One of the most powerful weapons in these platforms' arsenals is original content, and Netflix has been pouring money into original series and movies in the hopes of building a library people will want to keep coming back to.Image source: Getty Images.These investments have played an important role in the company's success in recent years. Since the content on Netflix is different from that of some of its peers, many customers are more than happy to pay for subscriptions to several companies in this space. The long-term plan for Netflix is simple: Replace regular TV.The company offers several advantages over cable: no ads, no long-term contracts, and on-demand movies and series streaming on any device. And while some cable providers have started to adapt to the new paradigm, Netflix is well on its way to continue its long winning streak in the streaming industry. Those factors make the company's stock worth a buy.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":56,"commentSize":24,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}